Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1050.Time spend outdoors in summer,47386,-0.0513213513948564,0.0524605305133535,-0.154143991201029,0.0515012884113164,0.327945972562022
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1060.Time spent outdoors in winter,45498,-0.0352955354039161,0.0579020859436939,-0.148783623853556,0.078192553045724,0.542153045003669
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X1070.Time spent watching television (TV),48120,-0.177735567186725,0.0519198833056661,-0.279498538465831,-0.0759725959076199,0.000620005411231406
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X1080.Time spent using computer,45493,-0.0023818849142244,0.051707469808902,-0.103728525739672,0.0989647559112236,0.963259290258955
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X1090.Time spent driving,43178,0.0823513632430028,0.0570562302647292,-0.0294788480758664,0.194181574561872,0.148947075072234
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1160.Sleep duration,49040,-0.0417148167647429,0.0473014701629542,-0.134425698284133,0.0509960647546472,0.37784525708806
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34850,0.0214808054426997,0.0111115083358138,-0.000297750895495302,0.0432593617808946,0.0532562606483603
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34850,-0.043071268256403,0.0123573023660144,-0.0672915808937913,-0.0188509556190148,0.000494607638480702
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34850,-0.028976056151123,0.0131317301963728,-0.0547142473360136,-0.00323786496623237,0.0273804824793567
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34850,-0.00884547658689234,0.0136531510591288,-0.0356056526627849,0.0179146994890002,0.51709237832774
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34850,-0.0247531203524851,0.0138231182321843,-0.0518464320875664,0.00234019138259623,0.0733891020255494
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34850,-0.0476352935686056,0.0373768457407246,-0.120893911220426,0.0256233240832146,0.202547833683026
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34850,-0.0610849932400559,0.0441226483449456,-0.147565383996149,0.0253953975160375,0.166274344342629
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34850,-0.0122603512871247,0.0221437418956805,-0.0556620854026585,0.0311413828284091,0.579823721478946
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34850,-0.00522694317030193,0.0171339426680149,-0.0388094707996111,0.0283555844590072,0.760327830126215
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34850,-0.0319683471418611,0.0113309790364313,-0.0541770660532664,-0.00975962823045576,0.00479769597493036
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34850,-0.0146763918436496,0.0180405871086383,-0.0500359425765808,0.0206831588892815,0.415950548217091
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34850,0.00172836117148138,0.008472265557079,-0.0148772793203935,0.0183340016633562,0.838358388585426
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34850,-0.0162355138512146,0.0114857176601323,-0.038747520465074,0.00627649276264476,0.157547003523063
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34850,-0.0443291568650874,0.0184230252754608,-0.0804382864049906,-0.0082200273251842,0.0161490660036118
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34850,0.0065321694823428,0.016911081484831,-0.0266135502279259,0.0396778891926115,0.699313103393051
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34850,-0.0582213784211009,0.0207489126075489,-0.0988892471318967,-0.0175535097103052,0.00503163787774616
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34850,-0.0329157949841258,0.0206131293800361,-0.0733175285689966,0.00748593860074506,0.110352738364713
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34850,-0.0139144406300275,0.012896603098463,-0.0391917827030149,0.01136290144296,0.280663727901675
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34850,-0.0147676068727014,0.0126611921183753,-0.039583543424717,0.0100483296793142,0.243510272696113
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34850,-0.0127805523197293,0.0140657469068786,-0.0403494162572115,0.0147883116177528,0.363580773913038
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120040.Fatigue severity over the past week,34858,-0.324414467584816,0.0903184730350612,-0.501438674733536,-0.147390260436096,0.000330802689263752
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120041.Waking unrefreshed severity over the past week,34861,-0.277497683284651,0.0889055570005485,-0.451752575005726,-0.103242791563576,0.00180896793168878
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120042.Cognitive symptoms severity over the past week,34860,-0.296025196788744,0.097475924694136,-0.48707800918925,-0.104972384388237,0.00240004692277508
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120098.Mobility problems today,34862,-0.212670049102154,0.102328102067977,-0.413233129155389,-0.0121069690489199,0.0377209872257702
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120099.Self-care problems today,34862,-0.415858644661187,0.150604662790247,-0.711043783730072,-0.120673505592303,0.00577466298024445
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120100.Problems doing usual activities,34862,-0.160354992608382,0.0996621552206157,-0.355692816840789,0.0349828316240244,0.107669879388029
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120101.Pain or discomfort today,34862,-0.209258097319649,0.0891131389089995,-0.383919849581288,-0.0345963450580098,0.0188938501129986
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120102.Anxiety or depression today,34862,-0.134395921474787,0.113982406544042,-0.357801438301109,0.0890095953515348,0.23840574146815
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120103.Scale to indicate how health is today,34848,0.0122617173348076,0.00366777302814269,0.00507288219964791,0.0194505524699673,0.000833363981606873
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34847,-0.404100720266624,0.111209826881335,-0.622071980954041,-0.186129459579208,0.000281653790483997
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34845,-0.276708618550353,0.117783328522153,-0.507563942453773,-0.045853294646934,0.0188396328915261
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34851,-0.285909248874519,0.0910443398555334,-0.464356154991364,-0.107462342757673,0.00169544952266186
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34856,-0.30317371698897,0.0920775638621434,-0.483645742158771,-0.122701691819169,0.000998200446505216
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34855,-0.44533583748335,0.129008702132223,-0.698192893662507,-0.192478781304193,0.00056016700069235
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120109.Feeling bad about self over the last two weeks,34843,-0.183136797201069,0.125014396375138,-0.42816501409634,0.0618914196942024,0.142991572613588
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120110.Trouble concentrating over the last two weeks,34859,-0.320442145572592,0.118214714384385,-0.552142985765987,-0.0887413053791969,0.00673287730229612
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34854,-0.423041673342691,0.171634420222973,-0.759445136979719,-0.0866382097056644,0.0137362978535362
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34821,-0.144296224971523,0.243001756174632,-0.620579667073801,0.331987217130756,0.55266258045564
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",32479,-0.151466858938817,0.125109740963588,-0.39668195122745,0.0937482333498152,0.226094940293096
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1269.Exposure to tobacco smoke at home,46809,-0.150053264743931,0.110213307271252,-0.366071346995585,0.0659648175077223,0.173378749638827
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,45750,0.0815658355029467,0.0661477529297837,-0.0480837602394294,0.211215431245323,0.217560765954872
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1289.Cooked vegetable intake,48218,0.0751604004109895,0.0492747744224182,-0.0214181574569501,0.171738958278929,0.127192379461128
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1299.Salad  or  raw vegetable intake,47496,0.114716836582748,0.0507508162176442,0.015245236796165,0.21418843636933,0.0238081439979382
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1309.Fresh fruit intake,48109,-0.160110132408657,0.0521769230894326,-0.262376901663945,-0.0578433631533696,0.00215358932611476
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1319.Dried fruit intake,47236,-0.127021806115724,0.0549267293155499,-0.234678195574202,-0.0193654166572464,0.0207572327493032
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X134.Number of self-reported cancers,49168,-0.21667196538385,0.0995135696745515,-0.411718561945971,-0.0216253688217289,0.0294687193797439
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X135.Number of self-reported non-cancer illnesses,49169,-0.311468157428268,0.0497709924857003,-0.409019302700241,-0.213917012156295,3.97582214020877e-10
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X136.Number of operations, self-reported",49169,-0.189083154667372,0.0473295449292663,-0.281849062728734,-0.0963172466060096,6.49100266629662e-05
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X137.Number of treatments or medications taken,49169,-0.354238494082373,0.048454957413971,-0.449210210613756,-0.25926677755099,2.75530291921077e-13
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1438.Bread intake,48704,-0.00879533622348869,0.00199426050442143,-0.0127040868121547,-0.0048865856348227,1.03751451690087e-05
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1458.Cereal intake,48120,-0.239808972146514,0.0490497438318908,-0.33594647005702,-0.143671474236008,1.02104313295484e-06
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1488.Tea intake,48406,-0.000828080854128537,0.0019684585104682,-0.00468625953464621,0.00303009782638914,0.673997142646016
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1498.Coffee intake,47572,0.0478969380978349,0.0489817980928201,-0.0481073861640924,0.143901262359762,0.328160109658011
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1528.Water intake,47350,0.0166332089998996,0.0494709693740248,-0.0803298909731889,0.113596308972988,0.736707520285568
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1568.Average weekly red wine intake,44281,0.391154455231991,0.0551780624085268,0.283005452911278,0.499303457552703,1.4089795259607e-12
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,44284,0.220998234135186,0.0577521389656033,0.107804041762603,0.334192426507768,0.000130393743902688
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1588.Average weekly beer plus cider intake,44338,0.285558427402705,0.0567310235409497,0.174365621262443,0.396751233542966,4.86795365081798e-07
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1598.Average weekly spirits intake,44282,0.0667310734274683,0.0592631966246349,-0.0494247919568162,0.182886938811753,0.260177651905194
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1608.Average weekly fortified wine intake,44314,0.0957839646440547,0.10541370117491,-0.110826889658769,0.302394818946879,0.363549817249566
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1737.Childhood sunburn occasions,43755,0.0487362493860152,0.0580544541369625,-0.0650504807224314,0.162522979494462,0.401206523803625
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X1807.Father's age at death,43910,0.00362326213169688,0.00227375605305631,-0.000833299732293482,0.00807982399568724,0.11106557039136
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X1845.Mother's age,36194,0.00552715665540739,0.00497356091207293,-0.00422102273225555,0.0152753360430703,0.26647109870117
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X1873.Number of full brothers,48820,-0.0523982127057195,0.0474185184197768,-0.145338508808482,0.040542083397043,0.269165886092021
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X1883.Number of full sisters,48821,0.0197777003254811,0.0476874636576852,-0.073689728443582,0.113245129094544,0.678339692063147
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X20015.Sitting height,48988,-0.00630144421401782,0.00256856441250608,-0.0113358304625297,-0.00126705796550591,0.0141637610773405
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X20016.Fluid intelligence score,35264,0.2319649076925,0.0810915988862474,0.0730253738754549,0.390904441509545,0.00424252028307078
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X20018.Prospective memory result,35567,-0.171688774245021,0.107203375577106,-0.381807390376149,0.0384298418861065,0.109306261226944
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),35181,-0.00968520627020419,0.00336963185309693,-0.0162896847022742,-0.00308072783813422,0.0040627007826252
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),35186,-0.0100949198478781,0.00335790467280049,-0.016676413006567,-0.00351342668918913,0.00265432002730225
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X20023.Mean time to correctly identify matches,48914,-0.00726539039804242,0.00202123767192795,-0.0112270162350212,-0.00330376456106363,0.000325752496606619
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#1.Illnesses of father_Heart disease,46176,-0.00969220178993672,0.00448062995118698,-0.0184742364942632,-0.000910167085610241,0.030544331781418
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,45796,-0.00285665034732936,0.00999482628972749,-0.0224465098751952,0.0167332091805365,0.775024865361628
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,45761,-0.0116081137576402,0.0130905408170247,-0.0372655737590085,0.0140493462437282,0.375222784158051
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#12.Illnesses of father_Severe depression,45783,0.0028281626636214,0.0118491509035384,-0.0203961731073138,0.0260524984345566,0.811356093163612
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,45804,-0.00631364320579809,0.00788997557935051,-0.0217779953413251,0.00915070892972891,0.423599756928765
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#2.Illnesses of father_Stroke,45946,0.00194456500144134,0.00570060760138739,-0.00922862589727793,0.0131177559001606,0.733020845211944
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#3.Illnesses of father_Lung cancer,45908,0.00356966233394735,0.00723136401335085,-0.0106038111322203,0.017743135800115,0.621569464178899
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,45809,-0.00611228935331695,0.00880768115059797,-0.023375344408489,0.0111507657018551,0.487708762088799
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,45930,-0.00477037019809788,0.00676832447439747,-0.0180362861679169,0.00849554577172115,0.480939112602711
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#8.Illnesses of father_High blood pressure,46001,-0.000689282721209009,0.00507288124031242,-0.0106321299522214,0.00925356450980334,0.891920894517498
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#9.Illnesses of father_Diabetes,45874,-0.0207091146309789,0.00693774110184079,-0.0343070871905868,-0.00711114207137093,0.00283981065304966
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46841,-0.00959927000783399,0.00535705866814658,-0.0200991049974013,0.000900564981733319,0.0731668531067134
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46710,0.00671264492869096,0.0075386135403908,-0.008063037610475,0.0214883274678569,0.373244214512159
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46640,0.0108206069683693,0.0169657630442202,-0.0224322885983022,0.0440735025350408,0.523617987715262
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46671,-0.0116773365163651,0.0089377431283365,-0.0291953130479046,0.00584064001517448,0.19139254788819
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#2.Illnesses of mother_Stroke,46794,0.00237909810343136,0.00602124131472788,-0.00942253487343528,0.014180731080298,0.692760771079734
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46713,0.00349754492662485,0.0101259525799682,-0.0163493221301128,0.0233444119833625,0.729794651652608
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46677,-0.00400300020169212,0.00908491740204599,-0.0218094383097023,0.013803437906318,0.659493079655087
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46685,0.00901309514874685,0.00771079358207208,-0.00610006027211444,0.0241262505696081,0.242462019938241
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46716,-0.00979694358532875,0.00910265183778902,-0.0276381411873952,0.00804425401673773,0.281819258109897
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46896,-0.0021526266374301,0.00460631873042743,-0.0111810113490679,0.00687575807420765,0.640276240225517
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46763,-0.0140465313503881,0.00693933454289097,-0.0276476270544544,-0.000445435646321789,0.0429652170461041
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,44208,-0.0228955760444576,0.00735484066004878,-0.0373110637381532,-0.00848008835076202,0.00185534354458952
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,44081,-0.0200609928796292,0.030309265356618,-0.0794671529786005,0.0393451672193422,0.508060174297145
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,44077,-0.0142093625966742,0.0287797110547853,-0.0706175962640534,0.042198871070705,0.62150496482104
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,44127,0.00204877132593863,0.0095586666443378,-0.0166862152969635,0.0207837579488407,0.830287456973711
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,44089,-0.0174218254968285,0.0173813378490402,-0.0514892476809474,0.0166455966872904,0.316200198042756
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#2.Illnesses of siblings_Stroke,44120,-0.029205292213801,0.0122847287405908,-0.0532833605453589,-0.00512722388224306,0.0174488378904998
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,44094,0.00297455923005711,0.0141083468551222,-0.0246778006059824,0.0306269190660966,0.833017365253566
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,44100,-0.016757476772542,0.013686771232881,-0.0435835483889887,0.0100685948439047,0.220836670637199
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,44104,0.0131891016882923,0.0107827394252276,-0.00794506758515373,0.0343232709617383,0.221284844713968
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,44122,-0.0137881015421379,0.0137262651870688,-0.0406915813087928,0.013115378224517,0.315150937605806
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,44263,-0.00627658254693435,0.00561817154789403,-0.0172881987808066,0.00473503368693795,0.263928902122395
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,44180,-0.0313174049231559,0.00778349720415089,-0.0465730594432917,-0.0160617504030202,5.75945197293664e-05
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20127.Neuroticism score,45136,-0.0821768980769585,0.0495965436776434,-0.17938612368514,0.0150323275312226,0.0975571090749988
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,35264,0.211127094896209,0.0822284774515402,0.0499592790911906,0.372294910701228,0.0102631589426821
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X20161.Pack years of smoking,35842,-0.013009662432162,0.00347450861172456,-0.0198196993111422,-0.00619962555318192,0.000182287200320992
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,35842,-0.0129404242170526,0.00342528818698094,-0.0196539890635352,-0.00622685937056996,0.000159419152811531
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X20191.Fluid intelligence score,33359,0.198298116415984,0.0941436112016515,0.0137766384607466,0.38281959437122,0.0352274983164052
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,33360,0.212431383856563,0.0960097632068365,0.0242522479711634,0.400610519741963,0.0269725105554786
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X20240.Maximum digits remembered correctly,32915,0.239515882162022,0.101141881975999,0.0412777934890646,0.43775397083498,0.0179227598325879
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X20255.Spirometry QC measure,43246,0.00919572443407528,0.0612527992907785,-0.110859762175851,0.129251211044001,0.880666157872863
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X20261.avMSE,33205,0.00107888790063801,0.00413442370650245,-0.00702458256410678,0.00918235836538281,0.794140862831077
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X20262.Myopia diagnosis,33205,0.0135827809354214,0.123175989742697,-0.227842158960265,0.255007720831108,0.91219899549575
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X20280.Glucose-lactate,39966,-0.00138699295236488,0.0025991571934592,-0.00648134105154492,0.00370735514681516,0.593606732100422
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X20281.Spectrometer-corrected alanine,39987,-0.00914781519425968,0.00274749096610422,-0.014532897487824,-0.0037627329006954,0.000872733166561879
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,34935,0.0034710170007895,0.0162579357993264,-0.0283945371658902,0.0353365711674692,0.830946367924525
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,34935,0.0178517801259212,0.0356415355592646,-0.0520056295702374,0.0877091898220799,0.616479935350635
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),34937,0.0172114131934829,0.0432218736702132,-0.0675034592001349,0.101926285587101,0.690488283643031
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),34937,0.013524980316891,0.0157955367243739,-0.0174342716628819,0.0444842322966639,0.391890066571859
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),34937,0.0314022742810803,0.0222483641706803,-0.012204519493453,0.0750090680556137,0.158163438712319
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,34938,-0.010030554591572,0.030829552359722,-0.0704564772166271,0.0503953680334831,0.744923011670529
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,34938,0.00192684930804452,0.0198589579777544,-0.0369967083283541,0.0408504069444432,0.922708252808626
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,34938,-0.0326189568324357,0.0224650838721613,-0.0766505212218718,0.0114126075570003,0.146555372952347
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,34938,0.0177202367946513,0.0332386392650457,-0.0474274961648384,0.082867969754141,0.593968094999538
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,34938,-0.00787248269912884,0.0356443288687824,-0.0777353672819424,0.0619904018836847,0.82520689281923
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,34938,0.00464097217574646,0.0239138508382996,-0.0422301754673208,0.0515121198188137,0.846126926196326
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,34938,0.00251831409253321,0.035062008132719,-0.0662032218475961,0.0712398500326625,0.94274377565202
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,34938,-0.00559273845281371,0.0274900141746788,-0.0594731662351841,0.0482876893295567,0.838792836956937
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),34941,0.0926273299926621,0.0467954236351882,0.000908299667693166,0.184346360317631,0.0478130425395679
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),34941,0.0247150382183317,0.0211836297528822,-0.0168048760973174,0.0662349525339809,0.243373560614394
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),34941,0.013829912058917,0.0270133170286178,-0.039116189317174,0.0667760134350079,0.608692318664013
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,34941,-0.0240563901096732,0.0569388520501038,-0.135656540127877,0.0875437599085303,0.672677949018878
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20600.Liking for adding salt to foods,35382,-0.0996057010937983,0.0799795298259523,-0.256365579552665,0.0571541773650682,0.213031535516081
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20601.Liking for aniseed,35382,-0.149088720962941,0.0792571766373448,-0.304432787172137,0.00625534524625435,0.0600045312664073
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20602.Liking for apple juice,35382,-0.190250024313389,0.0800447442281077,-0.34713772300048,-0.0333623256262977,0.017491368700249
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20603.Liking for apples,35382,-0.139128866597768,0.0814834207157972,-0.298836371200731,0.0205786380051945,0.0877842741232876
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20604.Liking for asparagus,35382,0.199925372463177,0.0798022006354093,0.0435130592177753,0.35633768570858,0.0122593807521784
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20605.Liking for aubergine,35382,0.213160183002806,0.0797750523192783,0.0568010804570207,0.369519285548591,0.00755776205883411
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20606.Liking for avocados,35382,0.150971988608761,0.0799617079921174,-0.00575295905578896,0.307696936273311,0.0590614626828448
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20607.Liking for bacon,35382,0.127968595375438,0.0815851201765604,-0.03193824017062,0.287875430921497,0.116804532055532
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20608.Liking for baked or steamed fish,35382,-0.0233251586347012,0.0802343390931264,-0.180584463257229,0.133934145987827,0.771279793933759
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20609.Liking for bananas,35382,-0.236155853931171,0.0820659023362774,-0.397005022510275,-0.0753066853520675,0.00401919124678618
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35382,0.165634407318903,0.0798439087803314,0.00914034610945338,0.322128468528352,0.0380726500715453
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20611.Liking for beef steak,35382,0.213201725943082,0.0808162113888281,0.0548019516209787,0.371601500265185,0.00835611864205396
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20612.Liking for beetroot,35382,-0.133025145121451,0.0800723700400516,-0.289966990399952,0.0239167001570506,0.0966971936104265
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20613.Liking for bell pepper,35382,0.0699786794405915,0.080021436303861,-0.0868633357149759,0.226820694596159,0.381877480591878
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20614.Liking for bicycling,35382,0.29263966156264,0.0797678364913999,0.136294702039496,0.448984621085784,0.000245713791456481
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20615.Liking for biscuits,35382,-0.36376200709435,0.0798566771143863,-0.520281094238547,-0.207242919950153,5.32559681119307e-06
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20616.Liking for bitter foods,35382,0.237192388934486,0.0800687086153032,0.0802577200484915,0.39412705782048,0.00306350911869705
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20617.Liking for bitter or ale,35382,0.538577201871684,0.080198835976076,0.381387483358575,0.695766920384793,2.02598938740011e-11
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20618.Liking for black olives,35382,0.107014557566422,0.0801793796649649,-0.0501370265769088,0.264166141709753,0.182022931697693
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20619.Liking for black pepper,35382,0.173145373884789,0.0809139080711781,0.0145541140652797,0.331736633704298,0.0324007714442874
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20620.Liking for blue cheese,35382,0.259703598797955,0.0798052491582445,0.103285310447796,0.416121887148114,0.00114263444767994
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20621.Liking for bolognese sauce,35382,-0.0439750538274253,0.0807821608111779,-0.202308089017334,0.114357981362483,0.586207625694779
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20622.Liking for broad beans,35382,-0.0997041815419256,0.079432220429603,-0.255391333583948,0.0559829705000963,0.209445548662533
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20623.Liking for broccoli,35382,0.0664916341885935,0.08085206357896,-0.091978410426168,0.224961678803355,0.410885990987989
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20624.Liking for brown rice,35382,-0.0216803861457023,0.0796271258964697,-0.177749552902783,0.134388780611378,0.785419741759283
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20625.Liking for brussel sprouts,35382,-0.020252972349446,0.0805825864634901,-0.178194841817887,0.137688897118995,0.801565159815617
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20626.Liking for burgers (meat),35382,-0.0613880710133737,0.0799979285425331,-0.218184010956739,0.0954078689299913,0.442887858848766
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20627.Liking for burn of spicy foods,35382,0.257706279525846,0.0787610747160198,0.103334573082447,0.412077985969245,0.00107324166110042
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20628.Liking for butter on bread,35382,-0.159377465242075,0.0810944976619158,-0.31832268065943,-0.00043224982471976,0.0494168348576138
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20629.Liking for butternut squash,35382,-0.0295776073147585,0.0792849709051839,-0.184976150288919,0.125820935659402,0.70911962994015
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20630.Liking for cabbage,35382,-0.0034782780866275,0.0802694485337486,-0.160806397212775,0.15384984103952,0.965437739720152
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20631.Liking for cake,35382,-0.274128789178926,0.0807357488762039,-0.432370856976286,-0.115886721381566,0.000689264350888736
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20632.Liking for cake icing,35382,-0.228048211635026,0.0793643666635292,-0.383602370295543,-0.0724940529745083,0.00407299797394233
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20633.Liking for capers,35382,0.11057182968445,0.0794372607383766,-0.045125201362768,0.266268860731668,0.163986543092545
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20634.Liking for cauliflower,35382,0.160783281811589,0.080862405546243,0.00229296694095235,0.319273596682225,0.0468124691741343
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20635.Liking for cereal or granola bar,35382,-0.194974171337386,0.0791243807681641,-0.350057957642988,-0.0398903850317848,0.0137586017012787
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20636.Liking for cheesecake,35382,-0.164612938164138,0.0801782841604203,-0.321762375118562,-0.00746350120971459,0.0401025334826949
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20637.Liking for cherries,35382,-0.195812660672362,0.0813569826434586,-0.355272346653541,-0.0363529746911836,0.0161181279756476
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20638.Liking for chicken,35382,-0.102297881593016,0.0822146351314563,-0.263438566450671,0.0588428032646379,0.213440233398748
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20639.Liking for chilli pepper,35382,0.1723310489064,0.0792533082981792,0.016994564641969,0.327667533170831,0.0297070939032826
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20640.Liking for chips or french fries,35382,-0.0477216001275858,0.0807776002125613,-0.206045696544206,0.110602496289034,0.554689130349476
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20641.Liking for cigarette smoking,35382,-0.0610345735036946,0.124310689587122,-0.304683525094454,0.182614378087065,0.623453592621837
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20642.Liking for cod,35382,-0.134762503843567,0.0821454581020009,-0.295767601723489,0.0262425940363545,0.100940400202868
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20643.Liking for coffee with sugar,35382,-0.256756785562191,0.0831819128259019,-0.419793334700959,-0.0937202364234236,0.00203216023875324
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20644.Liking for coffee without sugar,35382,0.181510459660959,0.0807445561245562,0.0232511296568293,0.33976978966509,0.0246108346566549
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20645.Liking for coriander,35382,0.147318474547058,0.0795282143397161,-0.00855682555878581,0.303193774652901,0.0640111428120334
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20646.Liking for corn flakes,35382,-0.443357258070456,0.0804097463564169,-0.600960360929033,-0.285754155211879,3.64275672078844e-08
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20647.Liking for cream,35382,-0.04313985791022,0.0798208932316696,-0.199588808644292,0.113309092823852,0.588898837456609
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20648.Liking for croissant,35382,-0.0391289546981621,0.079710435996183,-0.195361409250681,0.117103499854357,0.623521052508151
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20649.Liking for cucumber,35382,-0.0595868892647605,0.0802845366842829,-0.216944581165955,0.097770802636434,0.457994123042192
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20650.Liking for curry,35382,0.0922128831914282,0.0813198208924425,-0.0671739657577591,0.251599732140615,0.256854250764353
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20651.Liking for dairy products,35382,-0.157324773467298,0.0813610302607909,-0.316792392778449,0.00214284584385196,0.0531962536018948
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20652.Liking for dark chocolate,35382,-0.119334613211158,0.0806200752175978,-0.27734996063765,0.0386807342153331,0.138863818215302
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20653.Liking for diet fizzy drinks,35382,-0.275843160089214,0.0810123050620759,-0.434627278010883,-0.117059042167545,0.000665594741304277
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20654.Liking for dried fruit,35382,-0.186887256290321,0.0805670072684368,-0.344798590536457,-0.0289759220441849,0.0203894051869509
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20655.Liking for eggs,35382,-0.154978543279611,0.0819843542992218,-0.315667877706086,0.00571079114686374,0.0587547648974485
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20656.Liking for exercising alone,35382,0.157643021547563,0.0801666665173245,0.000516355173606958,0.314769687921519,0.0492884618763745
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20657.Liking for exercising with others,35382,0.202946565796542,0.0795940757459192,0.0469421773345401,0.358950954258543,0.0108012445112634
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20658.Liking for extra virgin olive oil,35382,0.178513435016692,0.0800735950398255,0.0215691887386342,0.33545768129475,0.0258221582487285
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20659.Liking for fatty foods,35382,-0.03683031130062,0.0799081924149764,-0.193450368433974,0.119789745832734,0.644879535262476
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20660.Liking for fresh tomatoes,35382,-0.0913974139663109,0.0830084827207409,-0.254094040098963,0.0712992121663412,0.270909179927666
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20661.Liking for fried chicken,35382,-0.150749091857922,0.0795477297394691,-0.306662642147281,0.00516445843143745,0.0581247135429944
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20662.Liking for fried or battered fish,35382,-0.149374148465906,0.0802370053831141,-0.30663867901681,0.00789038208499759,0.0626940940802589
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20663.Liking for fruit,35382,-0.202976501162238,0.0850922069920681,-0.369757226866691,-0.0361957754577843,0.01708922459269
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20664.Liking for garlic,35382,0.25017832438752,0.0808416706289195,0.0917286499548378,0.408627998820202,0.00197835158312648
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20665.Liking for gherkins,35382,0.109311549580326,0.0796114611510071,-0.0467269142756484,0.2653500134363,0.169778224940413
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20666.Liking for globe artichoke,35382,0.164154606795853,0.0804191668881085,0.00653303969516014,0.321776173896545,0.0412659191065198
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20667.Liking for goat's cheese,35382,0.120101938761417,0.0795038593224346,-0.0357256255105548,0.275929503033389,0.130926113744736
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20668.Liking for going to a cafe,35382,-0.162953270585445,0.0799703149742915,-0.319695087935056,-0.00621145323583394,0.0416215300445368
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20669.Liking for going to the gym,35382,0.0975098322725747,0.0796295044843812,-0.0585639965168124,0.253583661061962,0.220789665796607
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20670.Liking for going to the pub,35382,0.535491295471793,0.0798982645978139,0.378890696860077,0.692091894083508,2.21885759357116e-11
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20671.Liking for grapefruit,35382,0.0468739548984834,0.0797861076617915,-0.109506816118628,0.203254725915595,0.556890761057938
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20672.Liking for green olives,35382,0.159317636708471,0.0800567720498038,0.00240636349085563,0.316228909926086,0.0466246588370798
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20673.Liking for haddock,35382,-0.0251204089566623,0.0820360662975431,-0.185911098899847,0.135670280986522,0.759452824273962
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20674.Liking for ham,35382,0.0336650670481742,0.0811496432806809,-0.12538823378196,0.192718367878309,0.678263612992867
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20675.Liking for hard cheese,35382,-0.0250214728166044,0.0809797863035075,-0.183741853971479,0.13369890833827,0.757343065192645
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20676.Liking for herring,35382,0.0987900869245412,0.079528924681595,-0.0570866054513849,0.254666779300467,0.214209236012188
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20677.Liking for honey,35382,-0.216274628985225,0.0798011616249583,-0.372684905770143,-0.0598643522003069,0.00674183103517337
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20678.Liking for horseradish or wasabi,35382,0.157345660791905,0.0794726233559439,0.00157931901425534,0.313112002569556,0.047758271544794
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20679.Liking for ice cream,35382,-0.249038006277828,0.0816606172865809,-0.409092816159526,-0.0889831963961293,0.00229977566835599
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20680.Liking for jam,35382,-0.410117027706081,0.0801957226355833,-0.567300644071824,-0.252933411340338,3.2414857760895e-07
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20681.Liking for kiwi fruit,35382,-0.15395960250619,0.0799163216292416,-0.310595592899503,0.00267638788712382,0.0540825033373583
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20682.Liking for lager,35382,0.269599192396166,0.0795322137757891,0.11371605339562,0.425482331396713,0.000703401820161928
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20683.Liking for lamb,35382,0.112356481433533,0.0807913904893404,-0.0459946439255745,0.27070760679264,0.164362502011234
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20684.Liking for lemons,35382,-0.0704386904551884,0.0798814828026812,-0.227006396748444,0.0861290158380668,0.377921687382534
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20685.Liking for lentils or beans,35382,-0.0575476904487165,0.080193297461993,-0.214726553474223,0.0996311725767899,0.473021167953369
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20686.Liking for liver,35382,0.0636936537741627,0.0797053940652418,-0.0925289185937112,0.219916226142037,0.424252643433196
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20687.Liking for mackerel,35382,0.214348983666601,0.0805585129087185,0.0564542983655125,0.372243668967689,0.00781422425342664
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20688.Liking for marzipan,35382,-0.148463239540238,0.0795464199751686,-0.304374222691568,0.00744774361109285,0.0620324705266796
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20689.Liking for mayonnaise,35382,0.0203217762094208,0.0791135120005043,-0.134740707311568,0.175384259730409,0.79728802170781
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20690.Liking for melon,35382,-0.203140569832454,0.0805826542359111,-0.36108257213484,-0.0451985675300682,0.011728385839902
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20691.Liking for milk chocolate,35382,-0.139500791228181,0.0802100856899189,-0.296712559180422,0.0177109767240598,0.0820463148344048
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20692.Liking for mushrooms,35382,0.0862098361253259,0.0819664268071679,-0.0744443604167231,0.246864032667375,0.292942567419555
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20694.Liking for orange juice,35382,-0.135374089786544,0.0799818850132299,-0.292138584412475,0.0213904048393861,0.0905853608369225
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20695.Liking for oranges,35382,-0.115233694869205,0.0815483420639929,-0.275068445314631,0.0446010555762212,0.157680449604685
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20696.Liking for pasta,35382,-0.0446594104915707,0.0804746552499289,-0.202389734781431,0.11307091379829,0.578947181831408
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20697.Liking for pears,35382,-0.267861318581879,0.0808736570324339,-0.42637368636545,-0.109348950798309,0.000930849044966859
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20698.Liking for pizza,35382,-0.14016866148044,0.0798478207849609,-0.296670390218964,0.016333067258083,0.0792279866038096
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20699.Liking for plain yogurt,35382,-0.0844085272152107,0.0797194342277418,-0.240658618301585,0.0718415638711632,0.289719546150377
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20700.Liking for plums,35382,-0.11346490676246,0.0808747351768232,-0.271979387709033,0.0450495741841137,0.160671329922624
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20701.Liking for pollock,35382,0.052301759973676,0.0792150040783364,-0.102959648019863,0.207563167967215,0.509115429788979
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20702.Liking for pork chop,35382,0.0927632150365389,0.0802344289081117,-0.06449626562336,0.250022695696438,0.247659668868966
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20703.Liking for porridge,35382,-0.201656771920302,0.0808304951027237,-0.36008454232164,-0.0432290015189634,0.0126260732552331
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20704.Liking for potato crisps,35382,-0.164283973792989,0.0797216752526929,-0.320538457288267,-0.00802949029771133,0.0393679505800122
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20705.Liking for potatoes,35382,-0.13461508251377,0.0816423304004175,-0.294634050098588,0.0254038850710488,0.0992269329298714
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20706.Liking for prawns,35382,0.240673750987291,0.0803746567620149,0.0831394237337423,0.398208078240841,0.00275980409603021
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20707.Liking for raw carrots,35382,0.0151234969703618,0.0801834914186321,-0.142036146210157,0.172283140150881,0.850403278863018
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20708.Liking for red meat,35382,0.214579188981101,0.0807817824111235,0.0562468954552989,0.372911482506903,0.00791926924012184
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20709.Liking for red wine,35382,0.49745910211811,0.0809888544914103,0.338720947314946,0.656197256921274,8.59333045161192e-10
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35382,-0.115324088869963,0.0807523120590499,-0.273598620505701,0.0429504427657749,0.153303084343105
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20711.Liking for roast chicken,35382,-0.0623794451844833,0.0824491116960932,-0.223979704108826,0.0992208137398593,0.449327142961115
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20712.Liking for salad dressing,35382,-0.197733549397643,0.0795832055325161,-0.353716632241374,-0.0417504665539111,0.012993168687846
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20713.Liking for salad leaves,35382,-0.0524709779406077,0.080401566194414,-0.210058047681659,0.105116091800444,0.514028988892499
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20714.Liking for salami,35382,0.0990178769572794,0.0798348787647224,-0.0574584854215766,0.255494239336135,0.214913544783101
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20715.Liking for salmon,35382,0.0275782640901866,0.081106695682344,-0.131390859447208,0.186547387627581,0.733848617661613
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20716.Liking for salty foods,35382,-0.0195238201295544,0.0796651407369139,-0.175667495973906,0.136619855714797,0.806406894788731
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20717.Liking for salty pretzels,35382,-0.0206618940016624,0.079244292299747,-0.175980706909167,0.134656918905842,0.79430350126054
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20718.Liking for sardines,35382,0.0758473574090829,0.0796084239544326,-0.0801851535416051,0.231879868359771,0.340748005750727
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20719.Liking for sausages (meat),35382,0.125409710125257,0.0804817792441186,-0.0323345771932154,0.283153997443729,0.11922372857305
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20720.Liking for savoury biscuits,35382,-0.0599087074540827,0.0803977914248241,-0.217488378646738,0.0976709637385725,0.456204697255648
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35382,0.27139229620214,0.079158169436266,0.116242284107058,0.426542308297221,0.000610584444376517
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20722.Liking for skimmed milk,35382,-0.117207274733754,0.0801121163343365,-0.274227022749054,0.0398124732815453,0.143502685676126
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20723.Liking for smoked fish,35382,0.100678144458699,0.0805368541431552,-0.0571740896618849,0.258530378579283,0.211310640318149
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20724.Liking for soft cheese,35382,-0.0413504081018652,0.0796287360343028,-0.197422730729099,0.114721914525368,0.603575478313868
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20725.Liking for soy sauce,35382,0.0586906569745192,0.0802115346575485,-0.0985239509542758,0.215905264903314,0.464377947109936
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20726.Liking for soya milk,35382,-0.00372444884374224,0.0801718842731002,-0.160861342019019,0.153412444331534,0.962948333896123
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20727.Liking for spicy foods,35382,0.150263950437108,0.0798774565262252,-0.00629586435429336,0.306823765228509,0.0599901654338812
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20728.Liking for spinach,35382,0.134931053359439,0.0800041104135193,-0.0218770030510584,0.291739109769937,0.0917356759122998
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20729.Liking for spirits,35382,0.371084485593296,0.0793008114536189,0.215654895144203,0.526514076042389,2.93230131388709e-06
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20730.Liking for strawberries,35382,-0.152540580866429,0.0831847207885043,-0.315582633611897,0.0105014718790396,0.0667338971745128
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35382,-0.235862703285949,0.0805489194123915,-0.393738585334236,-0.0779868212376619,0.00342075179444467
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20732.Liking for sweet foods,35382,-0.451418928042756,0.0802524059452972,-0.608713643695538,-0.294124212389973,1.92924427467132e-08
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20733.Liking for taking the stairs,35382,0.313048483356728,0.0809569199544401,0.154372920246026,0.471724046467431,0.000111281230897978
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20734.Liking for tea with sugar,35382,-0.205442901208916,0.0875506467793189,-0.377042168896381,-0.0338436335214509,0.0189762436717411
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20735.Liking for tea without sugar,35382,0.185729804027031,0.0817658672583877,0.025468704200591,0.345990903853471,0.023148970769696
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20736.Liking for tomato ketchup,35382,-0.17537896523493,0.0796891725132189,-0.331569743360839,-0.0191881871090204,0.0277846694660685
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20737.Liking for tinned tuna,35382,0.0631095352063448,0.0797766733228392,-0.09325274450642,0.21947181491911,0.428926439505283
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20738.Liking for turnip (white),35382,0.0489252195039067,0.0799810005105127,-0.107837541496698,0.205687980504512,0.540749831399408
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20739.Liking for vegetables,35382,0.0288805333519391,0.0831687245072965,-0.134130166682362,0.19189123338624,0.728412549688399
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20740.Liking for vinegar,35382,-0.0782817714505154,0.0798567211382882,-0.23480094488156,0.0782374019805294,0.326984019796533
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20741.Liking for watching television,35382,-0.257793714136109,0.0802862064632886,-0.415154678804155,-0.100432749468064,0.00132922275408489
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20742.Liking for whisky,35382,0.374719190323209,0.0800120471707963,0.217895577868448,0.531542802777969,2.87817970046439e-06
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20743.Liking for white bread,35382,-0.180865280419965,0.0794741540070372,-0.336634622273758,-0.025095938566172,0.0228905780215404
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20744.Liking for white rice,35382,-0.208055129445953,0.0799155883507966,-0.364689682613515,-0.0514205762783919,0.00924957940169523
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20745.Liking for white wine,35382,0.342861720576928,0.0799547431039217,0.186150424093241,0.499573017060614,1.8262996480134e-05
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35382,-0.14539279563502,0.0803525688149472,-0.302883830512317,0.0120982392422763,0.0704276758911542
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20747.Liking for whole milk,35382,-0.0525985186525009,0.0799792724318668,-0.20935789261896,0.104160855313958,0.51078420063613
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20748.Liking for wholemeal bread,35382,-0.0640036402175501,0.0821169906276061,-0.224952941847658,0.0969456614125577,0.43575946864449
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20749.Liking for working up a sweat,35382,0.315483957264274,0.0801346964395497,0.158419952242756,0.472547962285791,8.33610031939396e-05
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X21001.Body mass index (BMI),49046,0.0317144144509168,0.0102983167156531,0.0115297136882367,0.0518991152135968,0.00207572638607756
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X21002.Weight,49073,-0.00963436550418271,0.00496145056309457,-0.0193588086078481,9.00775994826398e-05,0.0521696267706953
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X21021.Pulse wave Arterial Stiffness index,35551,0.0033059827629629,0.00362267278136935,-0.00379445588852103,0.0104064214144468,0.361494540135319
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,35221,-0.210090143211226,0.0874063702785229,-0.381406628957131,-0.0387736574653216,0.0162617691925716
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,35223,0.191520291214808,0.0889070289884042,0.017262514397536,0.36577806803208,0.0312633157522948
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,35225,0.0414974002835716,0.0863168932122334,-0.127683710412406,0.210678510979549,0.630705511763708
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21040.Satisfaction with bowel habits,35200,-0.213657811554213,0.0801399644974669,-0.370732141969248,-0.0565834811391782,0.00769336760933751
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,35197,-0.307799424963607,0.0876071878160661,-0.479509513083096,-0.136089336844117,0.00044537355608439
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21042.Greatest number of times bowels opened per day,35197,-0.125619590150569,0.0868282751970546,-0.295803009536796,0.0445638292356576,0.148011947068464
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21043.Least number of times bowels opened per week,35167,0.2367885930788,0.08716225214758,0.0659505788695434,0.407626607288057,0.00661207943186319
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21044.Average number of times bowels opened per day,35180,-0.103924045899621,0.09461228527822,-0.289364125044932,0.0815160332456906,0.272061282241519
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,35228,0.108280535464735,0.0876308707061003,-0.0634759711192212,0.280037042048692,0.216634823670543
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,35223,0.0344481484721883,0.0874349571166857,-0.136924367476516,0.205820664420892,0.693604065927325
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,35227,0.31951718409039,0.100256844837904,0.123013768208099,0.516020599972682,0.00144431334949041
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,35227,0.448958195102323,0.122968346409852,0.207940236139012,0.689976154065634,0.000263227946987931
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,35226,0.324839305851068,0.10498882489179,0.11906120906316,0.530617402638976,0.00198275418178228
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,35224,0.226158305775145,0.248433058759412,-0.260770489393304,0.713087100943593,0.362676878273167
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,35228,0.311039426264598,0.10679841963634,0.101714523777371,0.520364328751824,0.00359863524281777
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,35226,0.284483903987427,0.0985188189078943,0.0913870189279538,0.477580789046899,0.00389437788328919
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,35101,-0.224969658761706,0.0989569362860625,-0.418925253882389,-0.0310140636410238,0.0230339862808561
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,35224,0.103587303934501,0.0888304049381619,-0.0705202897442968,0.277694897613298,0.243606137305812
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,35227,-0.0158254564270361,0.153220030172579,-0.31613671556529,0.284485802711218,0.917739255322818
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,35228,0.436244534831027,0.0877169956770241,0.26431922330406,0.608169846357994,6.74728860359833e-07
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,35227,0.285000717664482,0.0877437007595575,0.11302306417575,0.456978371153215,0.00116755369961606
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X21100.Water hardness (USGS classification),48933,0.0283220092674927,0.0479882295763269,-0.0657349207021081,0.122378939237093,0.555072125198121
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X2139.Age first had sexual intercourse,46477,-0.00245004173662494,0.0020249734665267,-0.00641898973101726,0.00151890625776738,0.22632827383545
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2149.Lifetime number of sexual partners,45004,0.123858390300103,0.0550931003157058,0.0158759136813199,0.231840866918887,0.0245788824810915
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X22032.IPAQ activity group,45775,0.139214049991808,0.0520038103119275,0.0372865817804298,0.241141518203186,0.0074355846736884
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X22033.Summed days activity,46117,0.00719464915610968,0.00201530717174751,0.00324464709948455,0.0111446512127348,0.000357934680913288
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X22034.Summed minutes activity,45775,0.00805990700646052,0.00203516297794104,0.00407098756969608,0.012048826443225,7.51496969108384e-05
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X22037.MET minutes per week for walking,45160,0.00577263618632664,0.00207901791692875,0.0016977610691463,0.00984751130350698,0.00549895930455551
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X22038.MET minutes per week for moderate activity,45775,0.0047830233931917,0.00206521743871398,0.000735197213312299,0.00883084957307109,0.0205705175183819
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X22039.MET minutes per week for vigorous activity,45775,0.209398029086074,0.0521180849260942,0.10724658263093,0.311549475541219,5.90039371366477e-05
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X22040.Summed MET minutes per week for all activity,45160,0.00704856835947809,0.00205810552770115,0.00301468152518383,0.0110824551937723,0.000616778277700356
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X2217.Age started wearing glasses or contact lenses,45804,0.00233318025371841,0.00212914955807331,-0.00183995288010528,0.0065063133875421,0.273169689954773
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X22501.Year ended full time education,33333,0.0338637966787213,0.00919448249350155,0.0158426109914582,0.0518849823659843,0.00023302632384284
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X22506.Tobacco smoking,33301,0.125398702930181,0.191273138417355,-0.249496648367834,0.500294054228197,0.512113508641692
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,47883,0.45024075540508,0.157214358671445,0.142100612409048,0.758380898401111,0.00418957390985324
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23098.Weight,48693,-0.0104133315526477,0.00499726914234489,-0.0202079790716437,-0.000618684033651718,0.0371905651456312
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23099.Body fat percentage,48662,0.0296601522123643,0.00446599278886014,0.0209068063461985,0.0384134980785302,3.18818973868372e-11
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23100.Whole body fat mass,48623,0.0192548289503746,0.00446234341341885,0.0105086358600736,0.0280010220406755,1.60397654785468e-05
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23101.Whole body fat-free mass,48688,-0.0253251558436523,0.00431809688712517,-0.0337886257424177,-0.016861685944887,4.56479951648845e-09
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23102.Whole body water mass,48693,-0.0257759361234198,0.00430637914394981,-0.0342164392455614,-0.0173354330012782,2.1935538691952e-09
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23104.Body mass index (BMI),48693,0.0325707660005192,0.0101303536265116,0.0127152728925565,0.0524262591084818,0.00130575301615974
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23105.Basal metabolic rate,48693,-0.0241718518436425,0.00448368737720535,-0.032959879102965,-0.0153838245843201,7.08309448861983e-08
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23106.Impedance of whole body,48693,0.021235981400768,0.00353669836293496,0.0143040526094154,0.0281679101921205,1.95262944316139e-09
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23107.Impedance of leg (right),48693,0.0164835218887761,0.00286375226113386,0.0108705674569537,0.0220964763205984,8.74271714270824e-09
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23108.Impedance of leg (left),48693,0.0157659818904438,0.00284948465653765,0.01018099196363,0.0213509718172576,3.18865556413314e-08
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23109.Impedance of arm (right),48693,0.0124041287237262,0.00350945079573049,0.00552560516409447,0.019282652283358,0.000409476471794866
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23110.Impedance of arm (left),48693,0.0153375879661386,0.00350415899799442,0.0084694363300695,0.0222057396022076,1.20949259152647e-05
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23111.Leg fat percentage (right),48693,0.0343789217040275,0.00455421942066977,0.0254526516395148,0.0433051917685403,4.57983515988387e-14
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23112.Leg fat mass (right),48693,0.0276468270503394,0.00489655232239244,0.0180495844984502,0.0372440696022286,1.66265327169326e-08
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23113.Leg fat-free mass (right),48692,-0.0260709193490352,0.00474137875749462,-0.0353640217137247,-0.0167778169843458,3.87492554254489e-08
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23114.Leg predicted mass (right),48692,-0.0262486125358211,0.00477661227451244,-0.0356107725938654,-0.0168864524777767,3.94928457730822e-08
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23115.Leg fat percentage (left),48692,0.0351192023537036,0.00475335184522541,0.0258026327370618,0.0444357719703454,1.54529616860072e-13
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23116.Leg fat mass (left),48692,0.0276807090311358,0.00518345720636574,0.017521132906659,0.0378402851556127,9.38520232744825e-08
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23117.Leg fat-free mass (left),48691,-0.0260318305892675,0.00515241681882681,-0.0361305675541681,-0.015933093624367,4.40224233970283e-07
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23118.Leg predicted mass (left),48691,-0.0262744911394919,0.0051928976342151,-0.0364525705025534,-0.0160964117764303,4.23623423292065e-07
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23119.Arm fat percentage (right),48691,0.0223613859407554,0.00502726604025121,0.0125079445018631,0.0322148273796478,8.71299648192518e-06
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23120.Arm fat mass (right),48690,0.00515316544271025,0.00549137025162308,-0.00560992025047098,0.0159162511358915,0.348044217833585
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23121.Arm fat-free mass (right),48689,-0.0226324518450058,0.0047338984271672,-0.0319108927622535,-0.0133540109277581,1.75718949099146e-06
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23122.Arm predicted mass (right),48689,-0.0232841203703198,0.00475827365294159,-0.0326103367300854,-0.0139579040105543,9.98780787834606e-07
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23123.Arm fat percentage (left),48687,0.0243876583804508,0.00473189588915254,0.0151131424377118,0.0336621743231897,2.57557291738583e-07
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23124.Arm fat mass (left),48687,0.0111826970063851,0.00526580995841659,0.000861709487888612,0.0215036845248816,0.0337122489997467
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23125.Arm fat-free mass (left),48683,-0.0243593706526041,0.00431453078085963,-0.032815850983089,-0.0159028903221193,1.66547759766429e-08
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23126.Arm predicted mass (left),48682,-0.0250648259270296,0.00433787658576295,-0.033567064035125,-0.0165625878189342,7.66514491673321e-09
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23127.Trunk fat percentage,48681,0.022832793698701,0.00379012303767995,0.0154041525448483,0.0302614348525537,1.72814362929451e-09
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23128.Trunk fat mass,48681,0.0172738613088737,0.00399095382711025,0.00945159180773764,0.0250961308100098,1.51022971597114e-05
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23129.Trunk fat-free mass,48680,-0.0210772394098737,0.00374881188754436,-0.0284249107094606,-0.0137295681102867,1.90849540778398e-08
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23130.Trunk predicted mass,48678,-0.0210527266279284,0.00375049388946902,-0.0284036946512877,-0.0137017586045691,2.01101670974772e-08
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23400.Total Cholesterol,39990,0.0612672345831404,0.00269737167984186,0.0559803860906503,0.0665540830756304,9.74542785455327e-112
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,39990,0.0402991110002087,0.00266276691457421,0.0350800878476433,0.0455181341527742,3.02675207930029e-51
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",39990,0.0351301797330842,0.00268376394395969,0.0298700024029232,0.0403903570632452,7.17254775454505e-39
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23403.VLDL Cholesterol,39990,0.0117676368252792,0.00277614803816941,0.00632638667046713,0.0172088869800912,2.26452571959334e-05
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23404.Clinical LDL Cholesterol,39990,0.045807798312586,0.00264684122499723,0.0406199895115914,0.0509956071135805,2.94338689564854e-66
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23405.LDL Cholesterol,39990,0.0431044513207894,0.002638607691593,0.0379327802452671,0.0482761223963117,2.57785514632869e-59
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23406.HDL Cholesterol,39990,0.0960701792400141,0.00291424341506127,0.090358262146494,0.101782096333534,1.02331239067746e-227
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23407.Total Triglycerides,39990,-0.0174973432875406,0.00281111445301722,-0.0230071276154543,-0.0119875589596269,5.00574739312031e-10
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23408.Triglycerides in VLDL,39990,-0.0195500062672315,0.00284915752038767,-0.0251343550071913,-0.0139656575272716,7.15853437906086e-12
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23409.Triglycerides in LDL,39990,-0.00630575831729699,0.00266588174382359,-0.0115308865351912,-0.00108063009940275,0.0180294235325447
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23410.Triglycerides in HDL,39990,-0.00786909274917256,0.00275574823031962,-0.013270359280599,-0.00246782621774611,0.0043044152887755
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,39990,0.0622449452392258,0.00270959934690173,0.0569341305192984,0.0675557599591532,3.41667828034478e-114
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23412.Phospholipids in VLDL,39990,-0.00395025439885339,0.00280223840376575,-0.00944264167023427,0.00154213287252748,0.158662026990331
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23413.Phospholipids in LDL,39990,0.0407818303529364,0.00265169765727639,0.0355845029446747,0.0459791577611981,7.61944590420909e-53
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23414.Phospholipids in HDL,39990,0.0776060293404919,0.00282192636484394,0.0720750536653978,0.083137005015586,2.93789890541622e-161
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23415.Total Esterified Cholesterol,39990,0.0649580315071597,0.00270552440004827,0.0596552036830651,0.0702608593312544,2.63787198360239e-124
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,39990,0.0180755276880792,0.00276069705459747,0.0126645614610682,0.0234864939150903,6.10439311743348e-11
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23417.Cholesteryl Esters in LDL,39990,0.0404686317633885,0.00264172930136738,0.0352908423327084,0.0456464211940685,1.90052911310677e-52
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23418.Cholesteryl Esters in HDL,39990,0.0974470257020074,0.00291059794705278,0.0917422537257839,0.103151797678231,1.73159377917334e-234
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23419.Total Free Cholesterol,39990,0.0511668586963198,0.00267974058565663,0.0459145671484328,0.0564191502442068,5.01099470679627e-80
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23420.Free Cholesterol in VLDL,39990,0.00319190138127616,0.00279282333803542,-0.00228203236127327,0.00866583512382559,0.253106574796236
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23421.Free Cholesterol in LDL,39990,0.0488258523680993,0.00264305130500858,0.0436454718102824,0.0540062329259161,4.21492644010573e-75
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23422.Free Cholesterol in HDL,39990,0.0847215810573614,0.00292583333115863,0.0789869477282905,0.0904562143864323,5.92809340292527e-178
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,39990,0.0430818437809049,0.00262955845757647,0.037927909204055,0.0482357783577548,1.20075909713769e-59
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23424.Total Lipids in VLDL,39990,-0.00858635024383831,0.00280117730459744,-0.0140766577608493,-0.00309604272682732,0.00217986296435598
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23425.Total Lipids in LDL,39990,0.0405239203325729,0.00264369189058941,0.0353422842270177,0.0457055564381282,1.6458804934421e-52
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23426.Total Lipids in HDL,39990,0.0845399292393144,0.00285746944469927,0.0789392891277038,0.0901405693509249,2.11521243339706e-185
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,39990,0.0879944880364861,0.00269710447867873,0.0827081632582758,0.0932808128146964,2.76341507811872e-223
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23428.Concentration of VLDL Particles,39990,0.00431516732987359,0.0027692425594629,-0.0011125480866737,0.00974288274642088,0.119202197974868
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23429.Concentration of LDL Particles,39990,0.02748642982945,0.00266851556399218,0.0222561393240253,0.0327167203348747,9.02349831863272e-25
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23430.Concentration of HDL Particles,39990,0.0878462517848241,0.00269743905028423,0.082559271246267,0.0931332323233812,1.60743541199664e-222
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23431.Average Diameter for VLDL Particles,39990,-0.029945821428901,0.00288581305831442,-0.0356020150231972,-0.0242896278346047,4.08628920807872e-25
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23432.Average Diameter for LDL Particles,39990,0.0307381869978269,0.00274774156534095,0.0253526135297587,0.0361237604658952,6.69967463616076e-29
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23433.Average Diameter for HDL Particles,39990,0.0497188211465796,0.00299761407240787,0.0438434975646602,0.0555941447284991,4.55668132127921e-61
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23434.Phosphoglycerides,39980,0.0637248524936704,0.00271267615930526,0.0584080072214321,0.0690416977659087,3.33043774495184e-119
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,39980,-0.0569892371537833,0.00292158940307431,-0.0627155523838089,-0.0512629219237576,2.21749373237266e-83
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23436.Total Cholines,39980,0.0694537575979173,0.00275100533931864,0.0640617871328528,0.0748457280629818,6.91109882837302e-137
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23437.Phosphatidylcholines,39980,0.0685260422826465,0.00276137412049493,0.0631137490064764,0.0739383355588166,1.92754386829293e-132
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23438.Sphingomyelins,39980,0.0711111573544184,0.00277571164631,0.0656707625276508,0.076551552181186,8.74167607986251e-141
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23439.Apolipoprotein B,39990,0.0276822211291705,0.00267904587992679,0.022431291204514,0.032933151053827,6.44685740172761e-25
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23440.Apolipoprotein A1,39990,0.0847884998358746,0.00279183163231136,0.0793165098365444,0.0902604898352049,7.0296252263236e-195
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,39990,-0.0188616255974974,0.00273281146464928,-0.02421793606821,-0.0135053151267848,5.40313770397408e-12
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23442.Total Fatty Acids,39980,0.0226492909881192,0.00257925859998933,0.0175939441321401,0.0277046378440983,1.8462612365199e-18
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23443.Degree of Unsaturation,39980,0.0526939339108448,0.00274263033898163,0.0473183784464408,0.0580694893752488,5.49253242897746e-81
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23444.Omega-3 Fatty Acids,39980,0.037294216492557,0.00269617472569111,0.0320097140302024,0.0425787189549116,3.63636884931726e-43
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23445.Omega-6 Fatty Acids,39980,0.0428512024681994,0.00265183123549138,0.0376536132466363,0.0480487916897626,4.33305327506273e-58
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,39980,0.046265938554918,0.00266081309071442,0.0410507448971178,0.0514811322127183,7.42778210566529e-67
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23447.Monounsaturated Fatty Acids,39980,0.00167304013224893,0.00263005760733793,-0.00348187277813341,0.00682795304263126,0.524709049270446
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23448.Saturated Fatty Acids,39980,0.0207765576373668,0.00254467536386811,0.0157889939241853,0.0257641213505483,3.56122841616856e-16
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23449.Linoleic Acid,39980,0.0317634222481666,0.00265956126560275,0.0265506821675852,0.036976162328748,1.10567921068948e-32
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23450.Docosahexaenoic Acid,39980,0.0563077951437539,0.0026456686096126,0.0511222846689132,0.0614933056185946,1.34305050304404e-98
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,39980,0.0315447343763748,0.00270485539806789,0.0262432177961617,0.0368462509565879,2.99117819186135e-31
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,39980,0.0140874227424981,0.00265930165618703,0.00887519149637148,0.0192996539886247,1.19645456466706e-07
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,39980,0.0257597118310858,0.00271438380082883,0.0204395195814613,0.0310799040807103,2.76718125132689e-21
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,39980,-0.0457773112202404,0.00283946023689488,-0.0513426532845543,-0.0402119691559264,7.81850899163035e-58
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,39980,0.00412486865688174,0.00249069372113834,-0.000756891036549409,0.00900662835031289,0.0977266368705559
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,39980,0.0133227154520871,0.00272485727691469,0.00798199518933436,0.0186634357148399,1.0256418484026e-06
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,39980,0.0404518972764863,0.0026350824137705,0.0352871357454961,0.0456166588074764,1.16879108138085e-52
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,39980,0.0384300107828134,0.00281449289813125,0.0329136047024762,0.0439464168631507,4.08195595332051e-42
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,39980,-0.0233710211443268,0.00267862647999755,-0.028621129045122,-0.0181209132435316,3.03146536817413e-18
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23460.Alanine,39987,-0.0065032370019877,0.0026876819690396,-0.0117710936613053,-0.00123538034267008,0.0155512115259566
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23461.Glutamine,39948,-0.00476222829019917,0.00263392479233,-0.00992472088316597,0.00040026430276762,0.0706275121298202
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23462.Glycine,39978,-0.00815406249725737,0.00319461800497864,-0.0144155137870155,-0.00189261120749924,0.0107101577644247
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23463.Histidine,39975,0.0058971296790637,0.0026530821304404,0.000697088703400508,0.0110971706547269,0.0262524635740413
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),39980,-0.0130157975962533,0.0029722748001267,-0.0188414562045016,-0.00719013898800497,1.20252173162545e-05
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23465.Isoleucine,39988,-0.0166086857604537,0.00286638036579424,-0.0222267912774104,-0.010990580243497,7.0421912920793e-09
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23466.Leucine,39988,-0.00925068985348281,0.00293930446565746,-0.0150117266061714,-0.00348965310079418,0.00165245959642258
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23467.Valine,39980,-0.0126300716425049,0.00295959846192389,-0.0184308846278757,-0.00682925865713408,1.99280464342261e-05
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23468.Phenylalanine,39983,-0.0164660169834279,0.00271188139308716,-0.0217813045138787,-0.011150729452977,1.30512428124781e-09
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23469.Tyrosine,39977,-0.00817046748688495,0.00283237104004663,-0.0137219147253764,-0.00261902024839355,0.00392554652715691
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23470.Glucose,39971,-0.00152987843936263,0.00259377865878783,-0.00661368461058677,0.00355392773186151,0.555318939227359
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23471.Lactate,39972,-0.00284194148224097,0.00273131798284091,-0.00819532472860916,0.00251144176412722,0.29812891408014
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23472.Pyruvate,39945,-0.00131849854558166,0.00261442285525119,-0.006442767341874,0.00380577025071068,0.614048251203912
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23473.Citrate,39988,-0.00926396706669999,0.00270369177449936,-0.0145632029447187,-0.00396473118868124,0.000613768132934672
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23474.3-Hydroxybutyrate,39757,0.00537802796656216,0.00300175598979958,-0.00050541377344502,0.0112614697065693,0.0732197791021435
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23475.Acetate,39978,0.00134329415927082,0.0025536853409263,-0.00366192910894473,0.00634851742748636,0.598883312672917
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23476.Acetoacetate,39989,0.00737276286085228,0.00272258031679794,0.00203650543992832,0.0127090202817762,0.00677899368719023
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23477.Acetone,39989,0.0113258834786558,0.00268787856152096,0.00605764149807473,0.0165941254592369,2.53169578491423e-05
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23478.Creatinine,39777,-0.019324280402618,0.00333512015501431,-0.025861115906446,-0.0127874448987899,7.05102548977812e-09
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23479.Albumin,39988,0.030466912009492,0.00266312332837558,0.0252471902858759,0.0356866337331082,3.8414386110898e-30
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23480.Glycoprotein Acetyls,39990,-0.0127634836580223,0.00279313600287306,-0.0182380302236535,-0.00728893709239107,4.93819287610339e-06
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,39990,-0.0268683171053217,0.00282226142570786,-0.0323999494997091,-0.0213366847109343,2.07740819090256e-21
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,39990,-0.0258984424368903,0.00280286403826155,-0.0313920559518829,-0.0204048289218976,2.90131478011773e-20
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,39990,-0.0287885562855832,0.00289717673910106,-0.0344670226942212,-0.0231100898769451,3.57862208112778e-23
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,39990,-0.0231225931853377,0.00285400630300356,-0.0287164455392247,-0.0175287408314507,5.9670557069801e-16
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,39990,-0.0224416196571886,0.00285211651800215,-0.0280317680324729,-0.0168514712819044,3.91639439907534e-15
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,39990,-0.0229806540639291,0.00283602085384606,-0.0285392549374674,-0.0174220531903908,5.90246712425335e-16
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,39990,-0.0259454290983566,0.00274986673965757,-0.0313351679080855,-0.0205556902886278,4.65958233452841e-21
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,39990,-0.0240741793342238,0.00293687223455401,-0.0298304489139496,-0.0183179097544979,2.72334579892696e-16
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,39990,-0.0231306960721384,0.00291750463695616,-0.0288490051605725,-0.0174123869837043,2.42982937547451e-15
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,39990,-0.0233230142231467,0.00291533376074535,-0.0290370683942076,-0.0176089600520858,1.3632659647883e-15
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,39990,-0.0138365589564275,0.00290565728052073,-0.0195316472262481,-0.00814147068660689,1.94106105021105e-06
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,39990,-0.00652793015148338,0.00290694395584789,-0.0122255403049452,-0.000830319998021514,0.0247466015368839
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,39990,-0.0205688696555895,0.00289414877654117,-0.0262414012576102,-0.0148963380535688,1.2562902070897e-12
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,39990,-0.0256223121741908,0.00292328408226328,-0.0313519489754268,-0.0198926753729547,2.13373479819851e-18
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23495.Concentration of Large VLDL Particles,39990,-0.0190096153990191,0.0028963999213604,-0.0246865592448854,-0.0133326715531527,5.49559060553818e-11
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23496.Total Lipids in Large VLDL,39990,-0.0172441547587963,0.0028881145606109,-0.0229048592975937,-0.011583450219999,2.43235762651804e-09
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23497.Phospholipids in Large VLDL,39990,-0.0217871043841233,0.00294388206761796,-0.0275571132366545,-0.0160170955315921,1.4488570600437e-13
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23498.Cholesterol in Large VLDL,39990,-0.0115818723447651,0.0029153752202626,-0.0172960077764798,-0.00586773691305043,7.15041844559739e-05
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,39990,-0.00423346490930498,0.00289725069059913,-0.00991207626287927,0.00144514644426931,0.143987940003288
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,39990,-0.0182023872827771,0.00293741718254848,-0.0239597249605721,-0.012445049604982,5.9638627441583e-10
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23501.Triglycerides in Large VLDL,39990,-0.0171676277459806,0.00284490634217499,-0.0227436441766435,-0.0115916113153176,1.64399605453643e-09
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,39990,0.0151955075792344,0.00274073343633102,0.00982367004402561,0.0205673451144432,3.01670050911135e-08
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23503.Total Lipids in Medium VLDL,39990,0.00919719683692466,0.00274841926140162,0.00381029508457749,0.0145840985892718,0.000821452399739471
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23504.Phospholipids in Medium VLDL,39990,0.0167538050219361,0.0027346312302736,0.0113939278105998,0.0221136822332724,9.2780547130616e-10
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23505.Cholesterol in Medium VLDL,39990,0.0339870918230539,0.0026767082795748,0.0287407435950873,0.0392334400510205,1.08400767503302e-36
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,39990,0.0401742206904272,0.00266122658407274,0.0349582165856446,0.0453902247952098,5.34169777009829e-51
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,39990,0.0232166965316981,0.00271758669741741,0.01789022660476,0.0285431664586362,1.47230171219888e-17
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23508.Triglycerides in Medium VLDL,39990,-0.00902686232411419,0.00281652508342178,-0.0145472514876209,-0.0035064731606075,0.00135451651330804
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23509.Concentration of Small VLDL Particles,39990,-0.00414025281686767,0.00283012816591991,-0.00968730402207069,0.00140679838833534,0.143516696931049
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23510.Total Lipids in Small VLDL,39990,0.000592364089698151,0.00283381757832024,-0.00496191836380952,0.00614664654320583,0.834425471731667
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23511.Phospholipids in Small VLDL,39990,0.0148185511894188,0.00277889656051374,0.00937191393081191,0.0202651884480258,9.87060869157588e-08
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23512.Cholesterol in Small VLDL,39990,0.0163976145918543,0.00280406448714497,0.0109016481970502,0.0218935809866585,5.1179237119429e-09
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,39990,0.0107210421601873,0.0028555461628588,0.00512417168098409,0.0163179126393906,0.000174577715342961
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,39990,0.0252996591165803,0.00272182696217832,0.0199648782707107,0.0306344399624498,1.73756570217951e-20
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23515.Triglycerides in Small VLDL,39990,-0.0191310839941307,0.00285060542708328,-0.024718270631214,-0.0135438973570475,2.02141851145398e-11
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,39990,0.0180673248818048,0.00271277087906886,0.0127502939588299,0.0233843558047798,2.8623639847104e-11
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,39990,0.0179362078178524,0.00272956718369134,0.0125862561378174,0.0232861594978875,5.21299207221587e-11
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,39990,0.00974941182975439,0.0027213627251957,0.00441554088837082,0.015083282771138,0.000341678803907942
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,39990,0.0350765338337609,0.00273558518030747,0.0297147868803582,0.0404382807871635,2.22912359293933e-37
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,39990,0.0400940926486899,0.00274946936772526,0.0347051326879484,0.0454830526094314,9.76668804684226e-48
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,39990,0.0222392579350918,0.00272051105412635,0.0169070562690041,0.0275714596011794,3.28077555062534e-16
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,39990,-0.0150743744444157,0.00277413423257605,-0.0205116775402648,-0.00963707134856667,5.62699916557196e-08
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23523.Concentration of IDL Particles,39990,0.0371033953713501,0.00267509219216959,0.0318602146746977,0.0423465760680025,2.16922989724057e-43
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23524.Total Lipids in IDL,39990,0.0521713283216467,0.00271791137733514,0.0468442220220698,0.0574984346212236,7.59949568661212e-81
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23525.Phospholipids in IDL,39990,0.0472675280591528,0.00272289908357811,0.0419306458553397,0.0526044102629659,1.20572231474986e-66
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23526.Cholesterol in IDL,39990,0.0569789828509459,0.00272228413465645,0.0516433059470193,0.0623146597548726,1.74737389611189e-95
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23527.Cholesteryl Esters in IDL,39990,0.0573622732931531,0.00272576579137375,0.0520197723420606,0.0627047742442457,1.74085358471319e-96
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23528.Free Cholesterol in IDL,39990,0.0541163278561569,0.00270456355621818,0.0488153832859693,0.0594172724263446,1.44828491438301e-87
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23529.Triglycerides in IDL,39990,-0.00629519442531593,0.00268784489787974,-0.0115633704251602,-0.00102701842547165,0.0191928446260294
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23530.Concentration of Large LDL Particles,39990,0.0293516425826069,0.00265640159090608,0.024145095464431,0.0345581897007828,3.07015969257112e-28
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23531.Total Lipids in Large LDL,39990,0.0465319979812929,0.00264966872415238,0.0413386472819542,0.0517253486806315,3.83065078171316e-68
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23532.Phospholipids in Large LDL,39990,0.0484456922891385,0.00265432434827705,0.0432432165665155,0.0536481680117615,2.22256288363922e-73
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23533.Cholesterol in Large LDL,39990,0.0483192179966154,0.00264725030984288,0.0431306073893234,0.0535078286039075,2.18351245733807e-73
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,39990,0.0463765416095927,0.00264595613983257,0.0411904675755209,0.0515626156436645,6.87324613545484e-68
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23535.Free Cholesterol in Large LDL,39990,0.0526647947282143,0.0026628038574064,0.0474456991676978,0.0578838902887308,1.25056431118827e-85
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23536.Triglycerides in Large LDL,39990,-0.00296739403349183,0.00266354985114662,-0.00818795174173921,0.00225316367475554,0.265270563872531
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23537.Concentration of Medium LDL Particles,39990,0.0256312825195663,0.00268404834329729,0.0203705477667036,0.030892017272429,1.56911920701958e-21
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23538.Total Lipids in Medium LDL,39990,0.0319411592908643,0.00266313224282779,0.0267214200949218,0.0371608984868067,6.04335884838503e-33
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23539.Phospholipids in Medium LDL,39990,0.0321809987306488,0.00267281667716711,0.0269422780434013,0.0374197194178963,3.47668615918406e-33
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23540.Cholesterol in Medium LDL,39990,0.0343872245176349,0.00265559441861341,0.0291822594571527,0.0395921895781172,4.419277557164e-38
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,39990,0.0302697856126322,0.00266973052611298,0.0250371137814507,0.0355024574438136,1.22414918005666e-29
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,39990,0.0434106710062017,0.00263047388196409,0.0382549421975521,0.0485663998148513,1.7545632471571e-60
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23543.Triglycerides in Medium LDL,39990,-0.00894075661897389,0.00267876156322818,-0.0141911292829011,-0.00369038395504667,0.000847621245200438
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23544.Concentration of Small LDL Particles,39990,0.017763230654866,0.00269244764453297,0.0124860332715814,0.0230404280381506,4.36891753839387e-11
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23545.Total Lipids in Small LDL,39990,0.0250639594651528,0.00265090962568707,0.0198681765988061,0.0302597423314994,3.86645805137412e-21
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23546.Phospholipids in Small LDL,39990,0.0222241949987797,0.00264521866212879,0.0170395664210073,0.0274088235765521,4.92425460058207e-17
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23547.Cholesterol in Small LDL,39990,0.0300208748263734,0.00265301549191535,0.0248209644622193,0.0352207851905274,1.5760534436366e-29
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,39990,0.0260284642243394,0.00265907111607366,0.020816684836835,0.0312402436118437,1.54702867233326e-22
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23549.Free Cholesterol in Small LDL,39990,0.0374329299196755,0.002640676050691,0.0322572048603212,0.0426086549790299,3.14646187044769e-45
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23550.Triglycerides in Small LDL,39990,-0.0164570067195567,0.00270249215092052,-0.0217538913353609,-0.0111601221037525,1.1686591054386e-09
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,39990,0.0345810430144777,0.00306925075513843,0.0285653115344064,0.0405967744945491,2.73000435810713e-29
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23552.Total Lipids in Very Large HDL,39990,0.0314890225900246,0.00308078050585837,0.0254506927985422,0.037527352381507,2.03288864890393e-24
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23553.Phospholipids in Very Large HDL,39990,0.0267196738351138,0.00306659925068511,0.020709139303771,0.0327302083664567,3.36385851367124e-18
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23554.Cholesterol in Very Large HDL,39990,0.0401539485106232,0.00311265585670073,0.0340531430314897,0.0462547539897566,8.25370251235113e-38
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,39990,0.048443870853459,0.00312121921570351,0.0423262811906801,0.0545614605162379,8.90065936221148e-54
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,39990,0.0111979448271846,0.00304110961586634,0.0052373699800866,0.0171585196742826,0.000232307725693716
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23557.Triglycerides in Very Large HDL,39990,-0.0100280890573359,0.00257671330637644,-0.0150784471378338,-0.0049777309768381,0.000100064355194441
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23558.Concentration of Large HDL Particles,39990,0.0734411916493061,0.00304757697455127,0.0674679407791856,0.0794144425194266,3.4415136744528e-125
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23559.Total Lipids in Large HDL,39990,0.0706386416035484,0.00302599214271557,0.0647076970038259,0.0765695862032709,9.0022067743975e-118
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23560.Phospholipids in Large HDL,39990,0.0682172467573778,0.00299772039823219,0.0623417147768427,0.0740927787379129,3.84384605567128e-112
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23561.Cholesterol in Large HDL,39990,0.0743559146363233,0.00306808784027933,0.0683424624693759,0.0803693668032708,1.46648653791396e-126
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,39990,0.0766504089341004,0.00307467100215566,0.0706240537698753,0.0826767640983255,1.30360168373431e-133
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23563.Free Cholesterol in Large HDL,39990,0.0649607940895881,0.00304523909364212,0.0589921254660495,0.0709294627131266,4.90082738393213e-99
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23564.Triglycerides in Large HDL,39990,0.00410552542560515,0.00270795011835841,-0.00120205680637733,0.00941310765758764,0.12952160894685
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23565.Concentration of Medium HDL Particles,39990,0.0823297173766498,0.00276206217854678,0.0769160755066981,0.0877433592466015,4.6562975583516e-188
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23566.Total Lipids in Medium HDL,39990,0.0771151927651983,0.00272503233346051,0.0717741293916157,0.0824562561387809,2.563825574811e-170
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23567.Phospholipids in Medium HDL,39990,0.0701540929020425,0.00269069344389724,0.0648803337520039,0.0754278520520811,1.31682582348023e-145
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23568.Cholesterol in Medium HDL,39990,0.088149906756635,0.00278094306154954,0.0826992583559979,0.0936005551572721,2.14600804382788e-211
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,39990,0.0881875134140178,0.00277523176874973,0.0827480591472683,0.0936269676807673,2.15265037029155e-212
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,39990,0.0847590474599151,0.00280653437593448,0.0792582400830835,0.0902598548367467,8.19591546191216e-193
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23571.Triglycerides in Medium HDL,39990,-0.00286350960127933,0.00278626858015519,-0.0083245960183835,0.00259757681582483,0.304102426084637
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23572.Concentration of Small HDL Particles,39990,0.0673701657804335,0.00260955621670142,0.0622554355956988,0.0724848959651683,7.0592908792524e-143
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23573.Total Lipids in Small HDL,39990,0.0603346855667861,0.00262572347358097,0.0551882675585674,0.0654811035750048,2.97460402291804e-114
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23574.Phospholipids in Small HDL,39990,0.058754668937394,0.00261498690383868,0.0536292946058701,0.0638800432689178,1.97794670985035e-109
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23575.Cholesterol in Small HDL,39990,0.0707788156869811,0.00258702851333453,0.0657082398008454,0.0758493915731168,1.13904200670523e-159
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,39990,0.0707204915311772,0.00259794160579684,0.0656285259838154,0.075812457078539,3.86238420421267e-158
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23577.Free Cholesterol in Small HDL,39990,0.0623680533263659,0.00260390719438763,0.0572643952253662,0.0674717114273657,9.86620145208265e-124
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23578.Triglycerides in Small HDL,39990,-0.0237498042976022,0.00299161053090364,-0.0296133609381733,-0.0178862476570311,2.23279401067395e-15
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39655,-0.00809284241199018,0.00299562119200828,-0.0139642599483264,-0.00222142487565395,0.00691208359066321
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39655,0.0257801210598459,0.00286687968964674,0.0201610368681382,0.0313992052515535,2.81261136340955e-19
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39655,0.0214615935575273,0.00290252569818347,0.0157726431890877,0.0271505439259669,1.52653727561275e-13
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39655,0.028686895644007,0.00285574820529957,0.0230896291616199,0.0342841621263942,1.21663361917536e-23
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39655,-0.0190712527012446,0.0029108062220134,-0.0247764328963909,-0.0133660725060983,5.9342338700651e-11
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39927,-0.00818425501316478,0.00294477889132144,-0.0139560216401548,-0.00241248838617476,0.00545756167754278
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39927,0.0347335594631503,0.0029670801366741,0.0289180823952691,0.0405490365310316,1.79564645438081e-31
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39927,0.0368648823659204,0.00294811629742812,0.0310865744229613,0.0426431903088795,1.21155069473504e-35
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39927,0.0186848736265124,0.00298287594306474,0.0128384367781055,0.0245313104749193,3.88713626278868e-10
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39927,-0.0275192608242739,0.00296587948892277,-0.0333323846225625,-0.0217061370259853,2.02802881512303e-20
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,39990,-0.0363721354575414,0.00306464802549246,-0.0423788455875066,-0.0303654253275762,2.68039157628264e-32
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,39990,0.0223033985184886,0.0028755884736497,0.0166672451101352,0.027939551926842,9.50310022987864e-15
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,39990,0.0307903611516653,0.00291433085891427,0.0250782726681933,0.0365024496351373,5.69955098856298e-26
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,39990,-0.00510404301517303,0.00292548216559099,-0.0108379880597314,0.000629902029385318,0.0810667961151003
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,39990,-0.00537755754350832,0.00293905257554886,-0.0111381005915841,0.00038298550456744,0.0673223074774576
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,39990,0.0386579561404766,0.00281256152828356,0.0331453355450408,0.0441705767359123,1.19821334527334e-42
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,39990,0.0469234050206965,0.0029005330586196,0.041238360225802,0.0526084498155909,3.23124261864458e-58
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,39990,0.0473283248548048,0.0029162087522308,0.0416125557004324,0.0530440940091771,1.41607028697026e-58
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,39990,0.0444729904548051,0.0028414004784142,0.0389038455171132,0.0500421353924969,1.19635110682314e-54
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,39990,-0.0454028663003317,0.00287777970461548,-0.051043314521378,-0.0397624180792853,1.72888605505453e-55
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,39990,0.0520063153919269,0.00282111680523378,0.0464769264536687,0.0575357043301852,8.43943645311187e-75
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,39990,0.0363880517829922,0.00274443362689388,0.0310089618742802,0.0417671416917043,7.90713102413891e-40
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,39990,0.0222077677543683,0.00271416878098361,0.0168879969436405,0.0275275385650962,3.08396241605567e-16
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,39990,0.0537163352424478,0.00284337687859114,0.0481433165604092,0.0592893539244865,2.09500660746995e-78
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,39990,-0.0414858418002706,0.00276622810694777,-0.0469076488898883,-0.036064034710653,2.31175791095435e-50
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,39990,-0.0627672018215257,0.0026421772369921,-0.0679458692060302,-0.0575885344370212,8.51084667444285e-122
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,39990,0.0541797467591301,0.00280879955870452,0.0486744996240692,0.0596849938941909,1.31410101942841e-81
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,39990,0.0567868901994984,0.00284212254943506,0.0512163300026057,0.0623574503963911,2.53033980970018e-87
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,39990,0.025419658663721,0.00251219729504063,0.0204957519654413,0.0303435653620006,5.77494874839252e-24
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,39990,-0.0445288966247845,0.00278823547164433,-0.0499938381492074,-0.0390639551003616,8.49889127541082e-57
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,39990,-0.045270562096392,0.00261294747783427,-0.0503919391529472,-0.0401491850398368,2.13797144128542e-66
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,39990,0.0611179712703181,0.00271052682744681,0.0558053386885223,0.0664306038521139,3.52063445904508e-110
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,39990,0.0582409017351563,0.00268165518088619,0.0529848575806194,0.0634969458896933,1.63054987239202e-102
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,39990,0.0281172711730975,0.0025345763779525,0.0231495014723106,0.0330850408738844,1.88706075649245e-28
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,39990,-0.0549198533043291,0.00274466275205149,-0.0602993922983501,-0.0495403143103082,1.4363703474347e-87
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,39990,0.000869289198153249,0.00270167500345578,-0.00442599380862007,0.00616457220492657,0.747640914975997
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,39990,0.0540314174281371,0.00271362960186518,0.0487127034084813,0.0593501314477928,9.65806506565001e-87
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,39990,0.0279276037984691,0.00261746334193495,0.0227973756482766,0.0330578319486617,1.88037977598641e-26
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,39990,0.0501749113569344,0.00291771331671299,0.0444561932561769,0.0558936294576918,1.88025899549281e-65
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,39990,-0.0511536261242867,0.00267241531846755,-0.0563915601484831,-0.0459156921000903,2.07819026274394e-80
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,39990,-0.0107217082022909,0.00277116948919507,-0.0161532004011133,-0.00529021600346856,0.000109882884826114
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,39990,0.0528976690256745,0.00269524007303929,0.0476149984825175,0.0581803395688315,2.26407134086593e-84
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,39990,0.00551163360315959,0.00277023657447657,8.19699171855214e-05,0.0109412972891337,0.0466600470729752
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,39990,0.0385429291851312,0.00282670676890736,0.0330025839180728,0.0440832744521897,5.27537225196429e-42
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,39990,-0.0470627515088273,0.00266865835227861,-0.0522933218792934,-0.0418321811383612,1.07522195664528e-68
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,39990,-0.0205687020159286,0.00275776783177418,-0.025973926966206,-0.0151634770656512,9.38978420762321e-14
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,39990,0.0550451152534285,0.00264004469309614,0.0498706276549601,0.0602196028518969,8.86059127266043e-95
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,39990,0.0192820286266254,0.00273503670415003,0.0139213566864914,0.0246427005667595,1.8925533965771e-12
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,39990,0.0329627940252935,0.00269382580734965,0.0276828954428882,0.0382426926076988,3.25567122471391e-34
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,39990,-0.0416478554236502,0.00273512568794623,-0.0470087017720248,-0.0362870090752756,7.57051823564227e-52
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,39978,0.00944429170467112,0.00292615631115701,0.00370902533480337,0.0151795580745389,0.00125212459025533
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,39978,0.0123661299386675,0.00253949604346922,0.00738871769346785,0.0173435421838672,1.13373754117876e-06
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,39978,0.0490232851678055,0.00233105438832114,0.0444544185666961,0.053592151768915,2.32022632488342e-96
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,39978,-0.0519685675102157,0.00300315622866929,-0.0578547537184076,-0.0460823813020239,3.04778739981541e-66
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,39978,-0.0318895081077894,0.00286379413442714,-0.0375025446112666,-0.0262764716043122,1.18616226298649e-28
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,39990,-0.0259465695060394,0.00271244304980358,-0.0312629578836544,-0.0206301811284244,1.3425803109497e-21
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,39990,0.047198575891569,0.00284216425822849,0.0416279339454412,0.0527692178376969,3.26853430806094e-61
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,39990,0.0452979271670566,0.00273328820528979,0.0399406822846886,0.0506551720494246,5.66918817376665e-61
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,39990,0.0191191327824094,0.00273516598879919,0.0137582074443629,0.0244800581204558,2.9000314420512e-12
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,39990,-0.0522297681566352,0.00271925489673362,-0.0575595077542331,-0.0469000285590374,6.07483514603784e-81
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,39990,-0.0695668549028728,0.00287336669881009,-0.0751986536325406,-0.0639350561732051,2.57167853971272e-126
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,39990,0.0651034836004827,0.00286993504728006,0.0594784109078138,0.0707285562931516,1.83264628163562e-111
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,39990,0.048637275438395,0.00274619757919239,0.0432547281831779,0.0540198226936121,2.92655188993235e-69
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,39990,0.0857662361037698,0.00297241781587764,0.0799402971846496,0.0915921750228899,9.36522442616688e-177
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,39990,-0.0560155947827388,0.00283991201643871,-0.0615818223349587,-0.0504493672305189,3.48536465816782e-85
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,39990,0.00242107902623488,0.00267341763338085,-0.00281881953519159,0.00766097758766135,0.365160423509543
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,39990,0.0333799995680146,0.00263408105010228,0.0282172007098142,0.0385427984262151,1.48472378446066e-36
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,39990,0.0286593511838145,0.00259689789411432,0.0235694313113504,0.0337492710562785,3.55861092815251e-28
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,39990,0.0191076134109645,0.00284595957499918,0.0135295326439661,0.0246856941779629,1.98437315722056e-11
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,39990,-0.0642650389327097,0.00294274473204789,-0.0700328186075236,-0.0584972592578959,1.31399069641087e-103
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,48865,0.000741964723332783,0.00222890287495844,-0.00362668491158575,0.00511061435825132,0.739225758796186
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,48865,0.000900780960542449,0.00217274751269459,-0.00335780416433896,0.00515936608542385,0.678452669107181
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,47445,0.000297574118813197,0.00206637690981875,-0.00375252462443155,0.00434767286205794,0.885495954864682
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,47445,-0.00209317018817884,0.00225145867797215,-0.00650602919700425,0.00231968882064657,0.352540860564108
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,47445,0.000993068250596998,0.00222038618358825,-0.00335888866923598,0.00534502517042997,0.654699531760806
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,47445,0.00356263963398922,0.00205085809883165,-0.000457042239720821,0.00758232150769925,0.0823777688299376
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24009.Traffic intensity on the nearest road,48865,0.096869914134097,0.103922318864823,-0.106817830840956,0.30055765910915,0.351276458216403
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24010.Inverse distance to the nearest road,48865,0.00130361795432371,0.00195592255209605,-0.00252999024778455,0.00513722615643198,0.505100597319424
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24011.Traffic intensity on the nearest major road,48865,0.00055636182111698,0.00194086894789579,-0.00324774131675877,0.00436046495899273,0.774378625353254
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24012.Inverse distance to the nearest major road,48865,0.00152523758848174,0.00198323175783987,-0.00236189665688441,0.00541237183384788,0.441862652901494
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24013.Total traffic load on major roads,48865,0.0241397768587649,0.0715839418694933,-0.116164749205442,0.164444302922972,0.735952027173295
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24015.Sum of road length of major roads within 100m,48865,0.0284671689895968,0.0697964313924584,-0.108333836539622,0.165268174518815,0.683380806681431
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,48865,0.000554464048078252,0.00224063950360414,-0.00383718937898586,0.00494611747514237,0.804556341154136
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,48865,0.000666605175147366,0.00224034965322946,-0.00372448014518237,0.0050576904954771,0.766053392657505
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,48865,-0.000160302626280581,0.00221290703059099,-0.00449760040623893,0.00417699515367777,0.942252596998255
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,48826,-0.00299762472085705,0.00215737556554146,-0.00722608082931832,0.00123083138760422,0.16470290519792
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24020.Average daytime sound level of noise pollution,48865,0.00237310838445578,0.0019471283056078,-0.0014432630945355,0.00618947986344705,0.222944358485459
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24021.Average evening sound level of noise pollution,48865,0.00238090147584308,0.00194744636099745,-0.00143609339171193,0.00619789634339808,0.221504043969926
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24022.Average night-time sound level of noise pollution,48865,0.00236800605707948,0.00194713289164697,-0.00144837441054858,0.00618438652470755,0.223941875529776
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24023.Average 16-hour sound level of noise pollution,48865,0.00237210802467406,0.00194735328721415,-0.00144470441826567,0.0061889204676138,0.223192939172486
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24024.Average 24-hour sound level of noise pollution,48865,0.00235888542463759,0.00194739498076038,-0.00145800873765275,0.00617577958692794,0.225793415953534
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2405.Number of children fathered,48855,-0.0289081733964564,0.05432458554905,-0.135384361072594,0.0775680142796816,0.594636294292135
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",46543,0.00115789352865087,0.00229577017295047,-0.00334181601033204,0.00565760306763378,0.614014956025659
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",46543,-0.00424975464997708,0.00206290965154169,-0.0082930575669988,-0.00020645173295537,0.0394054785955884
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24502.Water percentage, buffer 1000m",46543,1.63000456893728e-05,0.00208011043346627,-0.00406071640390451,0.00409331649528326,0.993747812483542
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24503.Greenspace percentage, buffer 300m",46543,0.00321214986386405,0.00215306455162757,-0.00100785665732598,0.00743215638505408,0.135743812859139
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",46543,-0.00483298694039338,0.00208552590410034,-0.00892061771243004,-0.000745356168356711,0.0204934291532856
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24505.Water percentage, buffer 300m",46543,0.00094777683155442,0.00209559265541574,-0.00315958477306044,0.00505513843616928,0.651078873015417
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",48934,-0.000245362621394257,0.00220547596718208,-0.00456809551707113,0.00407737027428262,0.911417971791119
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24507.Natural environment percentage, buffer 300m",48934,-0.000434755786857529,0.00206747151160619,-0.00448699994960567,0.00361748837589061,0.833448277348841
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24508.Distance (Euclidean) to coast,48934,0.000935718361170977,0.00195386197075374,-0.00289385110150636,0.00476528782384831,0.632009872701011
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X2867.Age started smoking in former smokers,34621,0.00880537950959708,0.00362508336623686,0.00170021611177283,0.0159105429074213,0.0151690036895926
PON1,Serum paraoxonase/arylesterase 1,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35746,-0.083402329488598,0.110260790037992,-0.299513477963062,0.132708818985866,0.449428545214532
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35748,-0.0217650583660028,0.12548948822401,-0.267724455285063,0.224194338553057,0.862309486843075
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35748,-0.16681143183444,0.116272145166322,-0.394704836360432,0.0610819726915518,0.151426699186385
PON1,Serum paraoxonase/arylesterase 1,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35738,-0.0355647700090472,0.117842590916772,-0.266536248205921,0.195406708187827,0.762814127170984
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28739.Difficulty with standing for long periods,35749,-0.192904024206164,0.0984262920545122,-0.385819556633008,1.15082206798012e-05,0.0500482662845445
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28740.Difficulty with taking care of household responsibilities,35765,-0.196062734052175,0.112424626987185,-0.416415002947057,0.0242895348427075,0.0812110128389739
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28741.Difficulty learning a new task,35726,-0.157205631307912,0.133782340845174,-0.419419019364454,0.10500775674863,0.239999961812235
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28742.Difficulty with joining in community activities,35360,-0.0821694599619777,0.124636975819641,-0.326457932568475,0.16211901264452,0.509744659298933
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28743.Difficulty with being emotionally affected by health problems,35724,-0.338038038442068,0.10820535416658,-0.550120532608566,-0.125955544275571,0.00179101423716919
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35772,-0.309577352337789,0.145481285281939,-0.594720671490389,-0.0244340331851886,0.0333749920434129
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,34102,-0.0851362929155507,0.101334824966026,-0.283752549848962,0.113479964017861,0.400861688149735
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X2897.Age stopped smoking,34610,-0.0058930396864242,0.00380380392054182,-0.0133484953706862,0.00156241599783777,0.121374510822833
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34919,0.0022444100875662,0.00756636075229718,-0.0125856569869363,0.0170744771620687,0.766758703168406
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34919,-0.00606054890567748,0.00850360369739675,-0.0227276121525751,0.0106065143412202,0.476055508541875
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34919,0.019582916522632,0.0282390296289833,-0.0357655815501752,0.0749314145954392,0.488040209423849
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34919,0.0612935077784189,0.0290215722121525,0.00441122624259999,0.118175789314238,0.0347257451366853
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34919,0.0061886864901654,0.033656389759983,-0.0597778374394013,0.0721552104197321,0.854114671138855
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34919,-0.0132649138659083,0.0317970964352328,-0.0755872228789647,0.049057395147148,0.67656549813393
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34919,0.000351478828967475,0.0129739381617703,-0.0250774399681022,0.0257803976260372,0.978387893592056
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34919,-0.00317697818898967,0.0249330582435937,-0.0520457723464334,0.045691815968454,0.898611790980895
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29002.Recent lack of interest or pleasure in doing things,34892,-0.179869108196009,0.119724601206743,-0.414529326561225,0.0547911101692072,0.133055101206638
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29003.Recent feelings of depression,34892,-0.144795973473239,0.118455601975201,-0.376968953344634,0.0873770063981555,0.221615457468046
PON1,Serum paraoxonase/arylesterase 1,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34895,-0.0995694478455969,0.0938849913772911,-0.283584030945087,0.0844451352538936,0.288936511575593
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29005.Recent feelings of tiredness or low energy,34895,-0.20686284425067,0.0924236848241728,-0.388013266506049,-0.0257124219952911,0.025242744544621
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29006.Recent poor appetite or overeating,34902,-0.0133137693791858,0.147792059703829,-0.30298620639869,0.276358667640319,0.928222953834516
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29007.Recent feelings of inadequacy,34883,-0.0566312177413465,0.130429072241615,-0.312272199334912,0.199009763852219,0.664164169713283
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29008.Recent trouble concentrating on things,34900,-0.0489089456559257,0.12545856794986,-0.294807738837652,0.1969898475258,0.696666999574003
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34895,-0.0861202027078117,0.215587890963985,-0.508672468997222,0.336432063581598,0.689562845768852
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29010.Recent thoughts of suicide or self-harm,34879,-0.0252762636848949,0.231760541131716,-0.479526924303059,0.428974396933269,0.913156816035152
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29038#0.Substances taken for depression_None of options listed,34966,-0.0035133532877288,0.0152067780315226,-0.0333186382295131,0.0262919316540555,0.817292209762103
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),34966,0.0325938617191445,0.0271803685541202,-0.0206796606469312,0.0858673840852201,0.230506780417019
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),34966,-0.00141244639880451,0.017302110220324,-0.0353245824306395,0.0324996896330305,0.934940057078765
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),34966,0.0352297114928333,0.0515700748298576,-0.0658476351736876,0.136307058159354,0.494541642506417
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),34966,-0.0286875618120659,0.0339415899855409,-0.0952130781837261,0.0378379545595943,0.398028809378473
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),34966,-0.00635069911869558,0.0404467395164246,-0.0856263085708878,0.0729249103334967,0.875238895928911
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),34966,-0.0161613969565847,0.0404637186861298,-0.0954702855813992,0.0631474916682297,0.689608474796525
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),34966,-0.0464230563198415,0.0464658139336837,-0.137496051629861,0.0446499389901785,0.317794006669165
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),34966,-0.000362575537081875,0.0340873012708381,-0.0671736860279245,0.0664485349537608,0.991513654759469
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,34966,0.0215242659444103,0.0144047847396345,-0.00670911214527329,0.0497576440340939,0.13516136858418
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,34966,0.0273087394846473,0.0232757737025566,-0.0183117769723636,0.0729292559416582,0.240731918867873
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,34966,-0.0213193671625439,0.0368764688467453,-0.0935972461021648,0.0509585117770769,0.563197275387759
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,34966,-0.0203118037311771,0.0436794373011143,-0.105923500841361,0.0652998933790069,0.641933173864833
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,34966,-0.0124871384225174,0.0283339176972374,-0.0680216171091026,0.0430473402640679,0.659435428054471
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,34966,-0.00436264268080875,0.0417496542684898,-0.0861919650470487,0.0774666796854312,0.916779589191739
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,34966,-0.0342813318352221,0.0397098032320512,-0.112112546170042,0.0435498824995982,0.388007022827133
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,34966,-0.0368983365571867,0.0230045918777744,-0.0819873366376246,0.00819066352325122,0.108773517631217
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,34966,-0.00867680581799295,0.0225995180160779,-0.0529718611295057,0.0356182494935198,0.701037483451488
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,34966,-0.015615203927537,0.0334500388808932,-0.0811772801340876,0.0499468722790135,0.640643426412799
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29058.Recent feelings or nervousness or anxiety,34800,0.0419587182761444,0.117535646295859,-0.188411148463739,0.272328585016028,0.721113560472477
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29059.Recent inability to stop or control worrying,34806,-0.14244943032276,0.122912985483099,-0.383358881869635,0.0984600212241153,0.246523076507975
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29060.Recent worrying too much about different things,34805,-0.126769813843604,0.110272059044549,-0.342903049570921,0.089363421883712,0.250349038383125
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29061.Recent trouble relaxing,34801,-0.0879541351631525,0.117366836397979,-0.317993134503191,0.142084864176886,0.453647524131377
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29062.Recent restlessness,34808,-0.453028502316194,0.157230073433921,-0.761199446246678,-0.144857558385709,0.00397384442783671
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29063.Recent easy annoyance or irritability,34798,-0.0802669611747572,0.113166853445335,-0.302073993927615,0.1415400715781,0.478177559937768
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29064.Recent feelings of foreboding,34802,-0.166459547814405,0.140246535682665,-0.44134275775243,0.108423662123619,0.235309913327623
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,34966,-0.000989743329708067,0.0179856122934006,-0.0362415434247732,0.0342620567653571,0.956116508018958
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,34966,-0.00602855365250803,0.0274087461648515,-0.0597496961356169,0.0476925888306008,0.825917149652859
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',34966,0.0137985118134884,0.0378693076452668,-0.0604253311712345,0.0880223547982112,0.715592413321882
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,34966,-0.0484725836980057,0.0368839101791761,-0.120765047649191,0.0238198802531795,0.188828548624821
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#2.Symptoms of panic attack_Sweating,34966,-0.0417994033577812,0.0237195726699346,-0.0882897657908531,0.00469095907529063,0.0780779965868653
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,34966,-0.0297659668360229,0.0298094859128438,-0.0881925592251967,0.0286606255531509,0.31805548591818
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,34966,-0.0300026510088251,0.0279416085244686,-0.0847682037167835,0.0247629016991334,0.28296984625496
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,34966,-0.0398362655883871,0.0289211021776341,-0.0965216258565499,0.0168490946797757,0.168433410380075
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,34966,-0.059793146537936,0.0351739923555182,-0.128734171554752,0.00914787847887961,0.0891938963723714
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29076.Felt loved as a child,34777,0.197517473359137,0.0940652742020565,0.0131495359231063,0.381885410795168,0.0357876567028557
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29077.Physically abused by family as a child,34786,-0.239924580203038,0.11948564097672,-0.474116436517409,-0.00573272388866664,0.0446890114283024
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29078.Felt hated by family member as a child,34779,-0.263125202541738,0.136004829805924,-0.529694668961349,0.00344426387787222,0.0530757492995453
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29079.Sexually molested as a child,34762,-0.420753890518166,0.197972825283703,-0.808780628074224,-0.0327271529621082,0.0336003349711084
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29080.Someone to take to doctor when needed as a child,34773,0.140510378568916,0.140691483276107,-0.135244928652253,0.416265685790086,0.317973026244782
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34781,-0.365510853402292,0.207568912901789,-0.772345922689798,0.0413242158852151,0.0783025336613415
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34766,-0.012418164223235,0.179999984754374,-0.365218134341808,0.340381805895339,0.944999970379051
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34792,-0.272517498239314,0.197013408561724,-0.658663779020292,0.113628782541665,0.166640123162552
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34786,-1.39642710941053,0.51136348479278,-2.39869953960438,-0.394154679216681,0.00633614806311534
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34779,0.334783933794066,0.383271022554655,-0.416427270413058,1.08599513800119,0.38242925379697
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29086.Experienced a violent or sexual assault,34796,-0.164574083593718,0.215710937757267,-0.587367521597961,0.258219354410525,0.445529388633723
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29087.Experienced a life-threatening injury or illness,34789,-0.269965740666618,0.105980895406623,-0.4776882956636,-0.0622431856696373,0.0108798163190064
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29088.Experienced a marital separation or divorce,34789,-0.12298156766552,0.106699026325219,-0.332111659262949,0.086148523931909,0.249118087665818
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29089.Experienced the death of a spouse or partner,34800,0.108315223608626,0.160085086514116,-0.205451545959041,0.422081993176293,0.498678466479423
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34790,-0.214284652323967,0.129994705395151,-0.469074274898462,0.0405049702505289,0.0993191961835092
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29091.Frequency of drinking alcohol,34785,0.886737793528025,0.0875921216766408,0.715057235041809,1.05841835201424,6.67021975001232e-24
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,34273,0.59919773722843,0.0951491117346115,0.412705478228591,0.785689996228268,3.25303625326617e-10
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,34292,0.632293323763203,0.0949087241861666,0.446272224358316,0.818314423168089,2.95313961201362e-11
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29104.Ever used cannabis,34782,0.220878273617838,0.11988864006649,-0.014103460912483,0.455860008148159,0.0654700999328061
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29108.Ever thought that life not worth living,34761,-0.107160376140437,0.117602160021507,-0.337660609782591,0.123339857501717,0.362219890309806
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29109.Ever contemplated self-harm,34764,-0.0754970255135069,0.16505327733143,-0.399001449083109,0.248007398056095,0.647392475618452
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29111.Ever self-harmed,34776,-0.112316260682292,0.289638679571127,-0.6800080726417,0.455375551277116,0.69819177007509
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34778,-0.0934880635211906,0.176016904520479,-0.438481196381329,0.251505069338947,0.595346986036315
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,35448,-0.0237466891710749,0.0381658522212456,-0.0985517595247162,0.0510583811825664,0.533832874072568
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,35448,0.0172404404154867,0.0296316362113972,-0.0408375665588519,0.0753184473898252,0.560703403903461
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,35448,0.0200860628145308,0.0354648121938072,-0.0494249690853314,0.089597094714393,0.571163581892401
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,35448,0.0282669781802176,0.0588108389231762,-0.0870022661092077,0.143536222469643,0.630786084948452
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34767,0.0629115283349543,0.10085856182087,-0.134771252833951,0.260594309503859,0.532808339746156
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X29153.Pain or discomfort today,34778,-0.138532929895276,0.0919977379216753,-0.318848496221759,0.0417826364312077,0.132162035371217
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29154.Anxiety or depression today,34778,-0.159617732383052,0.12179421152054,-0.39833438696331,0.0790989221972062,0.190057670600847
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29166.Frequency of confiding in someone close,34622,0.00186001506742673,0.0914689419349494,-0.177419111125074,0.181139141259927,0.983776860899308
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34764,-0.0159157706124414,0.00712905901236124,-0.0298887262766694,-0.00194281494821335,0.0256163568677108
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34764,0.0115080042668551,0.00739344471333471,-0.00298314737128098,0.0259991559049911,0.119637123990935
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34764,0.0195277632263778,0.00785233562433523,0.00413718540268075,0.0349183410500748,0.0129133904899193
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34764,-0.0247152295788041,0.010769269612076,-0.0458229980184731,-0.0036074611391351,0.0217678627381184
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34764,-0.0186684335998916,0.0214404136805873,-0.0606916444138428,0.0233547772140596,0.383945125700478
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34764,0.0113608742798337,0.00793936754469271,-0.004200286107764,0.0269220346674314,0.152493928894037
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34759,-0.00773333838093465,0.00832683439658865,-0.0240539337982484,0.00858725703637911,0.353068072385438
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34759,0.00384696132720551,0.0130852079411196,-0.0218000462373888,0.0294939688917998,0.768773054620789
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34759,0.0299698828924127,0.0149488217430843,0.000670192275967426,0.0592695735088579,0.0450246479922312
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34759,-0.0182463057756476,0.0182849174526547,-0.0540847439828508,0.0175921324315555,0.318372713268402
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34759,0.00846805226718454,0.0309161581454911,-0.052127617697978,0.0690637222323471,0.784167759504378
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34759,0.0143581673484846,0.0119469958009024,-0.00905794442128414,0.0377742791182533,0.22947854689961
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29171.Frequency of feeling 'in tune' with people,34609,0.233768735201973,0.11123876884086,0.0157407482738871,0.451796722130059,0.0356382715348469
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29172.Freuency of feeling that lacks companionship,34722,0.0529273346804995,0.105436357862199,-0.153727926729411,0.259582596090411,0.615697031727822
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29173.Frequency of feeling left out,34696,-0.168520543746407,0.10892754614739,-0.38201853419529,0.0449774467024766,0.121893847115305
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29174.Frequency of feeling isolated from others,34725,0.0088051037067949,0.111783666529465,-0.210290882690956,0.227901090104545,0.937218820962181
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29175.Tendency to bounce back quickly after hard times,34771,0.121034301721582,0.090512472862786,-0.0563701450894784,0.298438748532643,0.181202984524279
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29176.Ability to make it through stressful events,34771,-0.245187291434033,0.087721079958455,-0.417120608152604,-0.0732539747154608,0.0052047496857102
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29177.Quick recovery from stressful events,34771,0.155035911231421,0.0903362097571641,-0.022023059892621,0.332094882355462,0.0861738167169453
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29178.Hard to snap back when something bad happens,34771,-0.209498698814376,0.0882429706221795,-0.382454921233848,-0.036542476394904,0.0176216462357979
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29179.Comes through difficult times with little trouble,34771,0.211541735415246,0.0897548836224698,0.0356221635152056,0.387461307315287,0.0184601489675469
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29180.Tendency to take a long time to get over setbacks,34771,-0.087330201877176,0.088572372191316,-0.260932051372155,0.0862716476178034,0.324183738469066
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29181.General happiness,34737,0.0215381625103419,0.0915281955185678,-0.157857100706051,0.200933425726735,0.813970370429641
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29182.Belief that own life is meaningful,34658,0.0271340152815122,0.0926793073844959,-0.1545174271921,0.208785457755124,0.769705563917438
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,34032,0.0309087585133343,0.0897845814609411,-0.14506902115011,0.206886538176779,0.730668124232478
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2946.Father's age,32895,0.00772788148146112,0.0061802761977571,-0.0043854598661428,0.019841222829065,0.21121779479476
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2966.Age high blood pressure diagnosed,34554,0.00675226130470066,0.00505113580958796,-0.00314796488209174,0.0166524874914931,0.181345277342717
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30000.White blood cell (leukocyte) count,48540,-0.0143500866261974,0.00209140399396185,-0.0184492384543626,-0.0102509347980321,7.01594493897131e-12
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,48541,0.00873312025545696,0.00226391552030927,0.00429584583565079,0.0131703946752631,0.00011489916769447
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30020.Haemoglobin concentration,48541,0.0202186572215239,0.00239152042191422,0.015531277194572,0.0249060372484757,2.99796293215882e-17
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30030.Haematocrit percentage,48541,0.0217869695526313,0.00234548120469674,0.0171898263914257,0.0263841127138369,1.71443898600765e-20
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30040.Mean corpuscular volume,48541,0.0160867007868048,0.00206970340917914,0.0120300821048137,0.0201433194687959,8.06894782332137e-15
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30050.Mean corpuscular haemoglobin,48541,0.0121202476805358,0.0020733874020328,0.00805640837255151,0.0161840869885201,5.12533301631747e-09
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,48541,-0.00351572221651134,0.00202492910045041,-0.00748458325339415,0.000453138820371457,0.0825404033279816
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,48541,-0.00868014388612408,0.0021123555578802,-0.0128203607795693,-0.00453992699267889,3.98575579849455e-05
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30080.Platelet count,48541,0.00728829127907879,0.00207114694199785,0.00322884327276299,0.0113477392853946,0.000434200529962945
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30090.Platelet crit,48541,0.00353923501259279,0.00211034508988271,-0.00059704136357731,0.0076755113887629,0.093540893879259
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,48541,-0.00793318704194402,0.00195870685751456,-0.0117722524826726,-0.00409412160121548,5.13637610280183e-05
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30110.Platelet distribution width,48541,-0.0182075064312569,0.00201218268207388,-0.0221513844881217,-0.0142636283743921,1.57744948303868e-19
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30120.Lymphocyte count,48507,-0.00411514913669117,0.00203403576604263,-0.00810185923813472,-0.00012843903524761,0.0430715458786414
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30130.Monocyte count,48507,-0.00777956927096216,0.00204521214411943,-0.0117881850734362,-0.00377095346848808,0.000142921398449355
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30140.Neutrophill count,48507,-0.0123827845195225,0.00206822470642138,-0.0164365049441084,-0.0083290640949366,2.17204290197957e-09
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30150.Eosinophill count,48507,-0.00810718838689204,0.00196546293206402,-0.0119594957337375,-0.00425488104004656,3.72525038695609e-05
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30160.Basophill count,48507,-0.04358152829819,0.0525590671223196,-0.146597299857936,0.0594342432615563,0.407006033356074
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30170.Nucleated red blood cell count,48507,0.267683231004344,0.271979493131879,-0.265396575534139,0.800763037542828,0.325027315332044
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30180.Lymphocyte percentage,48508,0.00700812127833167,0.00201440453964394,0.00305988838062956,0.0109563541760338,0.000504357086985869
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30190.Monocyte percentage,48508,0.00266835164294908,0.00202303949765139,-0.00129680577244763,0.0066335090583458,0.187190473121462
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30200.Neutrophill percentage,48508,-0.00495752545158467,0.00198697313437088,-0.0088519927949516,-0.00106305810821774,0.0126032584363716
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30210.Eosinophill percentage,48508,-0.00329893413591001,0.00195172278739849,-0.00712431079921105,0.00052644252739103,0.0909923924559109
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30220.Basophill percentage,48508,0.00119429644434305,0.00204397591516228,-0.00281189634937502,0.00520048923806112,0.559024679512656
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30230.Nucleated red blood cell percentage,48507,0.271013980549692,0.272143390435895,-0.262387064704661,0.804415025804046,0.319335163626565
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30240.Reticulocyte percentage,48188,-0.008868905616156,0.00215040736982006,-0.0130837040610033,-0.00465410717130869,3.73412407771407e-05
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30250.Reticulocyte count,48188,-0.00698126546328635,0.00217532655782699,-0.0112449055166272,-0.00271762540994545,0.00133275029104107
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30260.Mean reticulocyte volume,48188,0.00745203944890013,0.00204015138839236,0.00345334272765111,0.0114507361701491,0.000260184528710881
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30270.Mean sphered cell volume,48188,0.0172977768862969,0.00204675627564151,0.0132861345860395,0.0213094191865542,3.0793263445093e-17
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30280.Immature reticulocyte fraction,48188,-0.00352625336092505,0.00211856602687748,-0.00767864277360492,0.000626136051754811,0.0960379508422788
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30290.High light scatter reticulocyte percentage,48188,-0.00820055301246446,0.00217885186083394,-0.012471102659699,-0.00393000336522995,0.000167903599035883
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30300.High light scatter reticulocyte count,48188,-0.0069835564844298,0.00219063556363991,-0.011277202189164,-0.00268991077969557,0.00143528631496177
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30500.Microalbumin in urine,35919,-0.0118891055633924,0.00327484054699742,-0.0183077930355074,-0.0054704180912775,0.000284872729480801
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,48582,-0.00359585255841772,0.00218352305209408,-0.00787555774052212,0.000683852623686677,0.099612363066015
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30520.Potassium in urine,48545,0.00571264942142591,0.0020342583705286,0.00172550301518986,0.00969979582766196,0.00498642485706971
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30530.Sodium in urine,48551,-0.000224357181887258,0.00210928754760344,-0.00435856077519,0.00390984641141549,0.91529277321822
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30600.Albumin,46670,0.0316395106819732,0.00214269215872063,0.0274398340508807,0.0358391873130656,4.6717867434124e-49
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30610.Alkaline phosphatase,48168,-0.0130305257825148,0.00213108900047914,-0.0172074602234539,-0.00885359134157565,9.87015209758543e-10
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30620.Alanine aminotransferase,48153,0.0103392584417036,0.0023000431304143,0.00583117390609158,0.0148473429773157,6.98886817229939e-06
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30630.Apolipoprotein A,46613,0.0993689541640828,0.00222050816199538,0.0950167581665718,0.103721150161594,0
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30640.Apolipoprotein B,48024,0.0237305431696113,0.00198687573522293,0.0198362667285743,0.0276248196106482,9.12802083717203e-33
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30650.Aspartate aminotransferase,48095,0.00984021287955713,0.00211852110101596,0.00568791152156584,0.0139925142375484,3.42545691388328e-06
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30660.Direct bilirubin,46804,-0.00221763584621632,0.00215884676877038,-0.00644897551300627,0.00201370382057363,0.304325021274986
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30670.Urea,48157,-0.00630382600418662,0.00210885677217804,-0.0104371852776556,-0.00217046673071766,0.00280043038490038
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30680.Calcium,46662,0.0218117290676475,0.00213326398394863,0.0176305316591082,0.0259929264761868,1.79436311478889e-24
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30690.Cholesterol,48171,0.046551578118575,0.00198371179222395,0.0426635030058161,0.050439653231334,4.03817013901197e-120
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30700.Creatinine,48163,-0.0145191004623914,0.00265004568981623,-0.0197131900144312,-0.0093250109103516,4.33474234297227e-08
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30710.C-reactive protein,48096,-0.0201183886082732,0.00221333564780935,-0.0244565264779795,-0.0157802507385668,1.08675229753937e-19
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30720.Cystatin C,48177,-0.0438383812770719,0.00241615809863581,-0.0485740511503981,-0.0391027114037457,5.69203230798281e-73
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30730.Gamma glutamyltransferase,48159,0.018536366374853,0.00242010743628727,0.01379295579973,0.0232797769499761,1.95606476950905e-14
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30740.Glucose,46640,0.000174979453443995,0.00204568728725129,-0.00383456762956854,0.00418452653645653,0.93183640225456
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),48074,-0.0156288887441449,0.00204745300435606,-0.0196418966326827,-0.011615880855607,2.39287533751445e-14
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30760.HDL cholesterol,46650,0.10697090215532,0.00228039064796744,0.102501336485304,0.111440467825336,0
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30770.IGF-1,48080,0.011271976967865,0.00213701378149145,0.00708342995614178,0.0154605239795883,1.34438689513676e-07
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30780.LDL direct,48126,0.0330916096564425,0.00198892219301981,0.0291933221581237,0.0369898971547613,9.84858642863788e-62
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30790.Lipoprotein A,44232,-0.00327999280160792,0.00219177793632461,-0.00757587755680416,0.00101589195358832,0.134543938964761
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30810.Phosphate,46622,0.00287116851975318,0.0020867252760943,-0.00121881302139165,0.00696115006089802,0.168863281107776
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30830.SHBG,46537,0.00114495847601994,0.0027703677972382,-0.00428496240656693,0.0065748793586068,0.679400902394237
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30840.Total bilirubin,48086,0.00735004231256362,0.00218928295086359,0.00305904772887097,0.0116410368962563,0.000788630915275061
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30850.Testosterone,47977,0.0107987101757027,0.00343384141151412,0.00406838100913503,0.0175290393422704,0.00166457193104082
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30860.Total protein,46641,0.0168306475202943,0.00211868285477278,0.0126780291249396,0.0209832659156489,2.07336165822669e-15
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30870.Triglycerides,48149,-0.0312733625467088,0.00208155698587013,-0.0353532142390142,-0.0271935108544033,9.81280779646673e-51
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30880.Urate,48144,0.00356205819669698,0.00253667755711871,-0.00140982981525569,0.00853394620864965,0.160268671025579
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30890.Vitamin D,47577,0.00482709404746522,0.00226194088212858,0.0003936899184932,0.00926049817643725,0.0328515015784983
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X3137.Number of measurements made,47020,-0.0258402285670555,0.0636823058408816,-0.150657548015183,0.0989770908810724,0.684917940033317
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X3143.Ankle spacing width,40136,-0.00429670862795393,0.00372617944293443,-0.0116000203361054,0.00300660308019756,0.248887603839462
PON1,Serum paraoxonase/arylesterase 1,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",40136,0.00248965224531564,0.00270921626844609,-0.00282041164083869,0.00779971613146997,0.358137472352545
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X3146.Speed of sound through heel,40136,0.00128915653957856,0.00262993541601687,-0.00386551687581452,0.00644382995497163,0.624011873207518
PON1,Serum paraoxonase/arylesterase 1,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",40136,0.00186381137248666,0.00265163181214226,-0.00333338697931217,0.00706100972428549,0.482137103369506
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X3148.Heel bone mineral density (BMD),40117,0.00261041454191823,0.00266954582319506,-0.0026218952715441,0.00784272435538055,0.328169212438643
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X3526.Mother's age at death,40854,0.00667055990704533,0.0026520532498986,0.00147253553724406,0.0118685842768466,0.0119077050995554
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32390,-0.00504669479287602,0.0045952188349299,-0.0140533237093386,0.00395993412358659,0.272165510760047
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4100.Ankle spacing width (left),35262,-0.00965449337611813,0.0046805296116412,-0.0188283314149349,-0.000480655337301373,0.0391805244738365
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4101.Heel broadband ultrasound attenuation (left),35261,-0.00117560074368466,0.00339273885110225,-0.00782536889184507,0.00547416740447575,0.728974223517164
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4103.Speed of sound through heel (left),35262,0.002712083995318,0.0032522982115102,-0.003662420499242,0.00908658848987799,0.404368531896039
PON1,Serum paraoxonase/arylesterase 1,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",35262,0.00153110863339405,0.00329800104321182,-0.00493297341130112,0.00799519067808921,0.642481281821809
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4105.Heel bone mineral density (BMD) (left),35254,0.00213938627358453,0.00331360713836747,-0.00435528371761571,0.00863405626478478,0.518536946974044
PON1,Serum paraoxonase/arylesterase 1,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",35262,0.00153407758427835,0.00329824624477769,-0.00493048505548591,0.00799864022404262,0.641861314656146
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4119.Ankle spacing width (right),35250,-0.00729794217738803,0.00461875663110707,-0.0163507051743579,0.00175482081958184,0.11413922002588
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4120.Heel broadband ultrasound attenuation (right),35249,-0.00107767800009429,0.00342106986505515,-0.00778297493560239,0.00562761893541381,0.752762441221141
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4122.Speed of sound through heel (right),35250,0.00216492659860756,0.00324306688077918,-0.00419148448771962,0.00852133768493475,0.504440641087283
PON1,Serum paraoxonase/arylesterase 1,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",35250,0.0012299138951703,0.00330313583268544,-0.00524423233689317,0.00770406012723378,0.709646109248529
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4124.Heel bone mineral density (BMD) (right),35241,0.00151116109074861,0.00331239215465065,-0.00498112753236666,0.00800344971386387,0.648250710069246
PON1,Serum paraoxonase/arylesterase 1,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",35250,0.00123115363988494,0.00330315463899819,-0.0052430294525515,0.00770533673232139,0.709368312694605
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4194.Pulse rate,35598,-0.000559898640806901,0.00307649103678923,-0.00658982107291379,0.00547002379129999,0.855593794756869
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4195.Pulse wave reflection index,35598,0.00547255149321976,0.00322285711924568,-0.000844248460501783,0.0117893514469413,0.0895440149958247
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4196.Pulse wave peak to peak time,35590,-0.00400226180457056,0.00357474605542578,-0.0110087640732051,0.00300424046406396,0.262925572410783
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4198.Position of the pulse wave peak,35598,0.00529930232083473,0.00384618008083263,-0.00223921063759722,0.0128378152792667,0.168306259513035
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4199.Position of pulse wave notch,35598,-0.00652980678662954,0.00310925970578603,-0.0126239558099701,-0.000435657763288928,0.0357543206641392
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4200.Position of the shoulder on the pulse waveform,35598,0.00173484148555704,0.00391960096500687,-0.00594757640585642,0.0094172593769705,0.658063947319743
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4269.Number of triplets attempted (left),35395,0.0898084429906715,0.265358620073906,-0.430294452354185,0.609911338335528,0.735040774060321
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4270.Volume level set by participant (left),35317,0.0363358814469181,0.084169828242931,-0.128636981909227,0.201308744803063,0.665975344867766
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4276.Number of triplets attempted (right),35400,0.0883279999750423,0.264740190068462,-0.430562772559144,0.607218772509229,0.738661301116111
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4277.Volume level set by participant (right),35325,-0.0351209016692865,0.0838849284742469,-0.19953536147881,0.129293558140237,0.675463740657616
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X4288.Time to answer,35567,0.00111407703392782,0.00370186894881317,-0.00614158610574599,0.00836974017360164,0.763461690559352
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X4290.Duration screen displayed,35567,-0.00517107553733624,0.00340704773230318,-0.0118488890926505,0.00150673801797799,0.129120671804331
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X46.Hand grip strength (left),49062,0.014949820643834,0.00266771012820313,0.00972110879255584,0.0201785324951121,2.12170249659096e-08
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X47.Hand grip strength (right),49058,0.0144153627619987,0.00263149984308821,0.00925762306954583,0.0195731024544516,4.35223728547715e-08
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X48.Waist circumference,49115,-0.0108857701356858,0.00499362694077181,-0.0206732789395985,-0.00109826133177302,0.0292737873983572
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X4803.Tinnitus,35436,-0.12248896473207,0.0945853176518608,-0.307876187329717,0.0628982578655776,0.195360414918967
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X4825.Noisy workplace,35504,-0.177242930183819,0.0905855779897263,-0.354790663043683,0.000304802676044241,0.0504306374675483
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X4836.Loud music exposure frequency,35461,-0.195976626787275,0.122118823230094,-0.435329520318258,0.0433762667437083,0.108583252474524
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X49.Hip circumference,49108,0.00301379454499131,0.00366816379498342,-0.00417580649317618,0.0102033955831588,0.411309302584773
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X50.Standing height,49072,-0.0080558616550795,0.00277763380972558,-0.0135000239221416,-0.00261169938801736,0.0037324927615006
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X5057.Number of older siblings,34698,-0.0976564597133069,0.089884602292952,-0.273830280207493,0.078517360780879,0.277316341303469
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X51.Seated height,48988,-0.00492839323634131,0.00242106816802069,-0.00967368684566186,-0.000183099627020769,0.0418006649111345
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5181.Ever had eye surgery,33319,-0.213742070757512,0.198384813145963,-0.6025763045236,0.175092163008576,0.281351583738631
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5186.Duration visual-acuity screen displayed (right),33309,0.00357914862735955,0.0039869231252776,-0.00423522069818454,0.0113935179529036,0.369379669346598
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5188.Duration visual-acuity screen displayed (left),33306,-0.00161141385725541,0.00410882084152751,-0.00966470270664934,0.00644187499213851,0.694940013566969
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5190.Duration at which refractometer first shown (right),33261,-0.00231204283291231,0.00411382565116289,-0.0103751411091916,0.00575105544336696,0.574130983815039
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5193.Duration at which refractometer first shown (left),33258,-0.00187945889983036,0.00415309834881294,-0.0100195316635037,0.00626061386384299,0.650898351628389
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5199.logMAR, initial (right)",33288,-0.160664994064145,0.105199329034256,-0.366855678971287,0.0455256908429973,0.126767943577543
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5200.Final number of letters displayed (right),33288,0.2156393437083,0.628111434420911,-1.01545906775669,1.44673775517328,0.731377776862998
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5201.logMAR, final (right)",33232,-0.00599470725732112,0.00395075474098507,-0.0137381865496519,0.00174877203500962,0.129244695447287
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5202.Number of rounds to result (right),33288,0.00426677304706054,0.0986723280884662,-0.189130990006333,0.197664536100454,0.965510598487243
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5206.logMAR, initial (left)",33284,-0.069965815250918,0.104414249900324,-0.274617745055552,0.134686114553716,0.502840354101303
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5207.Final number of letters displayed (left),33284,0.023431947409677,0.62737733976082,-1.20622763852153,1.25309153334088,0.970208289068506
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5208.logMAR, final (left)",33246,-0.00522478088939211,0.0039965456933539,-0.0130580104483657,0.00260844866958153,0.191167322882537
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5209.Number of rounds to result (left),33280,0.113740261987432,0.0982839600288395,-0.0788962996690934,0.306376823643957,0.24722465956741
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33114,0.00966953686580181,0.00392728445538447,0.00197205933324824,0.0173670143983554,0.0138480523348708
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33114,0.013017250601989,0.00386518777502619,0.00544148256293768,0.0205930186410403,0.000763996991069796
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5256.Corneal hysteresis (right),33114,0.00333507439226798,0.00399539951551472,-0.00449590865814088,0.0111660574426768,0.403914687719647
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5257.Corneal resistance factor (right),33114,0.00949408207842506,0.00394086795879715,0.00176998087918264,0.0172181832776675,0.0160301855160175
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33089,0.00757564303036172,0.00395063990394087,-0.000167611181362375,0.0153188972420858,0.0552284817883317
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33089,0.0114699996945476,0.00392073922433985,0.00378535081484154,0.0191546485742537,0.0034566144365201
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5264.Corneal hysteresis (left),33089,0.00226346824683449,0.00395350996445303,-0.00548541128349346,0.0100123477771624,0.566997603236765
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5265.Corneal resistance factor (left),33089,0.0091466783596225,0.00393481626367053,0.00143443848282825,0.0168589182364167,0.0201404076739799
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,33882,-0.0192036543808213,0.522825347861692,-1.04394133618974,1.00553402742809,0.970701250468786
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",49069,0.00640489224028388,0.0108724148319413,-0.0149050408303211,0.0277148253108889,0.55580361501994
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",49069,-0.0193949889579137,0.0124623356642648,-0.0438211668598727,0.0050311889440453,0.119654978769112
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",49069,-0.0137666237782287,0.0312554552468906,-0.0750273160621343,0.0474940685056768,0.659612196881412
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",49069,0.00595914587274987,0.00493561249656186,-0.00371465462051139,0.0156329463660111,0.227300872877714
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",49069,-0.000786279116135427,0.00458064023451868,-0.00976433397579204,0.00819177574352119,0.863712295911977
PON1,Serum paraoxonase/arylesterase 1,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37569,0.0170194961939441,0.00595301912426411,0.00535157871038642,0.0286874136775017,0.00426000561481752
PON1,Serum paraoxonase/arylesterase 1,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37569,0.0163074863764154,0.0182650450423389,-0.0194920019065688,0.0521069746593996,0.371974922241907
PON1,Serum paraoxonase/arylesterase 1,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37569,0.0162089503595286,0.0114718883332859,-0.00627595077371186,0.038693851492769,0.157711643835183
PON1,Serum paraoxonase/arylesterase 1,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37569,0.00868736906361988,0.00692587609274546,-0.00488734807816122,0.022262086205401,0.20975294089312
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,49127,0.00720694963882067,0.0104206375384736,-0.0132174999365876,0.027631399214229,0.489194170187691
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,49127,0.00720694963882067,0.0104206375384736,-0.0132174999365876,0.027631399214229,0.489194170187691
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),49127,0.00619927379737524,0.00757737042946515,-0.00865237224437645,0.0210509198391269,0.413292477456407
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',49127,-0.00585761772672311,0.0133631587579445,-0.0320494088922944,0.0203341734388481,0.661143865339025
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),49127,-0.00576427031070881,0.0320948285485665,-0.0686701342658992,0.0571415936444816,0.857467420852755
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),49127,0.00498043404527543,0.0219079700727949,-0.0379591872974027,0.0479200553879535,0.820166032056214
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,49127,-0.0202146068137962,0.0334869760962114,-0.0858490799623705,0.0454198663347782,0.546079187036101
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,49068,-0.00554170386162733,0.00677630918668783,-0.0188232698675355,0.00773986214428083,0.413477697655255
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,49068,-0.0326795369409909,0.0118675712410958,-0.0559399765735386,-0.00941909730844318,0.00589806797932962
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,49068,-0.00615582650755383,0.00613766712825048,-0.0181856540789248,0.00587400106381712,0.315892655892586
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,49068,-0.0182346063860276,0.00906285670161338,-0.0359978055211898,-0.000471407250865342,0.0442314012811612
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,49068,-0.0252534637664398,0.00919168291148356,-0.0432691622729476,-0.00723776525993204,0.0060117711220456
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,49068,-0.0205924049871042,0.00522141093337228,-0.0308263704165139,-0.0103584395576946,8.04545311521001e-05
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,35947,-0.0418511626544718,0.0102693104931046,-0.0619790112209568,-0.0217233140879867,4.64266686139858e-05
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,35947,-0.035976565623067,0.00982703420242724,-0.0552375526598244,-0.0167155785863096,0.000253017166831699
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,35947,-0.0422679921495939,0.0141818136660149,-0.0700643469349831,-0.0144716373642047,0.00288780846885012
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,35947,0.0355465115050841,0.0105228621233581,0.0149217017433022,0.0561713212668659,0.000733872943384631
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,49025,-0.035410089759924,0.0182218013734995,-0.0711248204519829,0.000304640932135031,0.0519958731933747
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6151#2.Fractured bone site(s)_Leg,49025,-0.0284637218273737,0.0226513568657339,-0.072860381284212,0.0159329376294647,0.208912457150946
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6151#3.Fractured bone site(s)_Hip,49025,-0.0538748157255341,0.0432224881418196,-0.138590892483501,0.0308412610324324,0.212612295340807
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6151#4.Fractured bone site(s)_Spine,49025,0.00191438953584052,0.0412427634206512,-0.0789214267686359,0.082750205840317,0.96297787347355
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,49025,-0.0112787533216472,0.0171242201176524,-0.044842224752246,0.0222847181089515,0.510132257370459
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6151#6.Fractured bone site(s)_Arm,49025,-0.00916914959306492,0.0200443161482147,-0.0484560092435657,0.0301177100574359,0.647356902077271
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,49025,0.00404286074134717,0.00852551887246366,-0.0126671562486816,0.0207528777313759,0.635357370261886
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",34752,-0.0333250354004772,0.0145277930230823,-0.0617995097257185,-0.00485056107523588,0.0218308529174333
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",34752,-0.0349180556177446,0.0140671485570951,-0.062489666789651,-0.00734644444583818,0.0130823671889351
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",34752,-0.0210379169408036,0.0202536815128414,-0.0607351327059727,0.0186592988243656,0.298975503293134
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",34752,0.00332126005073488,0.00729608341335579,-0.0109790634394425,0.0176215835409122,0.64897325291315
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",37460,-0.0170494472313006,0.00634407992462078,-0.0294838438835573,-0.00461505057904385,0.00721326678637903
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",37460,0.0144948797320643,0.006997562301922,0.000779657620297147,0.0282101018438314,0.0383485831088636
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",37460,-0.00480546564489259,0.00621042787791804,-0.0169779042856119,0.00736697299582677,0.439085283504756
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",37461,0.00444618389646583,0.0144043201938981,-0.0237862836835745,0.0326786514765062,0.757579697257821
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",37461,-0.0204312148831251,0.00860689159352596,-0.037300722406436,-0.00356170735981426,0.0176263019579693
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",37461,-0.0826661456846087,0.0156880251519576,-0.113414674982446,-0.0519176163867718,1.40106032176555e-07
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,49068,-0.0320254302389037,0.0133234103823317,-0.0581393145882738,-0.00591154588953352,0.016239091850937
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,49068,-0.0484391523052913,0.0107002447830825,-0.069411632080133,-0.0274666725304496,6.01867434361042e-06
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,49068,-0.0240694929778279,0.0222687108390677,-0.0677161662224005,0.0195771802667447,0.279769448263403
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,49068,-0.0432245446926978,0.0120079806967648,-0.0667601868583568,-0.0196889025270388,0.00031939657908748
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,49068,-0.0257545479874151,0.0122944761876625,-0.0498517213152337,-0.00165737465959653,0.0362004625750467
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),49068,-0.0656779946632401,0.0149813805830562,-0.0950415006060303,-0.03631448872045,1.17113829932562e-05
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,49068,0.00994079251120722,0.00432854032033173,0.00145685348335702,0.0184247315390574,0.0216534061937352
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,33483,-0.0349522103506378,0.0108411177967981,-0.056200801232362,-0.0137036194689136,0.0012722696886879
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,33483,-0.0307337620500493,0.0130864761763425,-0.0563832553556807,-0.00508426874441796,0.0188881957530866
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,33483,0.0327687208020788,0.00972214567275104,0.0137133152834867,0.0518241263206708,0.000756076908780609
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,33483,-0.000649768959033391,0.00872741229845524,-0.0177554970640057,0.0164559591459389,0.940654179034174
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,49156,-0.0273978013173466,0.00525469271121191,-0.0376969990313219,-0.0170986036033712,1.86632020367557e-07
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,49156,-0.0621766211879275,0.0172686570227753,-0.0960231889525671,-0.0283300534232879,0.000318295138823272
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,49156,-0.0103142522717768,0.00463040725012893,-0.0193898504820295,-0.00123865406152412,0.0259243683197566
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,49156,-0.00287042402929793,0.00433346855412261,-0.0113640223953782,0.00562317433678239,0.50773202018576
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,49156,-0.0253862553839807,0.00737543880404128,-0.0398421154399016,-0.0109303953280598,0.00057858041282215
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,49156,-0.0107991363763716,0.00658905519185376,-0.0237136845524049,0.00211541179966181,0.101238838538843
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,49156,-0.00667174347508309,0.0046782150608416,-0.0158410449943326,0.00249755804416645,0.153845967793122
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,49156,-0.00706484355799461,0.0152545569964777,-0.0369637752710908,0.0228340881551016,0.643276063428672
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,42898,0.00664860683051091,0.00480833317089512,-0.00277572618444353,0.0160729398454654,0.166770520534778
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,42898,0.033524023621888,0.00472674099366256,0.0242596112743094,0.0427884359694666,1.37975921205335e-12
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,42898,-0.0302202412255397,0.00611160823060503,-0.0421989933575256,-0.0182414890935539,7.71153311896483e-07
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,42899,-0.0182788048504882,0.00948470532696368,-0.036868827291337,0.000311217590360575,0.0539760645465567
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,42899,-0.0145274364820482,0.00541358184685969,-0.0251380569018931,-0.00391681606220316,0.00729362256527314
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,48969,0.00904138436077695,0.00498108376787571,-0.00072153982425944,0.0188043085458133,0.0695164814659449
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,48969,0.00949691146585672,0.00391549619570767,0.00182253892226968,0.0171712840094438,0.0152972866721678
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,48969,-0.0114395333080936,0.00442391273973017,-0.0201104022779647,-0.00276866433822246,0.00972105948201099
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,48969,0.0188421125662224,0.0067541123893705,0.00560405228305624,0.0320801728493886,0.00528019184592303
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),48988,0.0183671285595465,0.00420428350003203,0.0101267328994837,0.0266075242196092,1.25622213611128e-05
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,48988,0.0201628245408834,0.00588278968018349,0.00863255676772373,0.031693092314043,0.000610536048742581
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),49068,0.00561648405788615,0.00430085036653325,-0.00281318266051901,0.0140461507762913,0.19160096113142
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,49068,0.0138129251133755,0.0053961576973844,0.00323645602650202,0.0243893942002489,0.0104812489146636
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,49068,-0.0230016538385462,0.0113266286018348,-0.0452018458981425,-0.000801461778949891,0.0422923397019144
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,49068,-0.00280713688802326,0.0105861504898062,-0.0235559918480434,0.0179417180719969,0.790880639025904
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,49068,-0.0327811974102124,0.0128372380683725,-0.0579421840242225,-0.00762021079620218,0.0106686859805655
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,49068,-0.0035507724432065,0.0130237915525309,-0.029077403886167,0.021975858999754,0.785134723148161
PON1,Serum paraoxonase/arylesterase 1,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",40136,0.0018644173773794,0.00265163566214697,-0.00333278852042867,0.00706162327518747,0.481995320332057
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X864.Number of days or week walked 10+ minutes,48746,0.126157560935804,0.0467208290769587,0.0345847359449653,0.217730385926643,0.00693468788330548
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X874.Duration of walks,46443,0.0034432105362557,0.00200883641269444,-0.000494108832625391,0.0073805299051368,0.0865401578424634
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,48215,0.082626988239036,0.0455999817649945,-0.00674897602035314,0.172002952498425,0.0700020918243107
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X894.Duration of moderate activity,44041,-0.031449359189337,0.0550122377257383,-0.139273345131784,0.0763746267531101,0.567547562449932
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X90087.No-wear time bias adjusted average acceleration,32622,0.0129070992700791,0.00442308156706858,0.00423785939862465,0.0215763391415335,0.0035409658741168
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,48148,0.193057413577009,0.0469470133355849,0.101041267439263,0.285073559714755,3.93439665284049e-05
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X914.Duration of vigorous activity,40296,0.00279869130991854,0.00239959941034846,-0.00190452353436445,0.00750190615420153,0.243510466699375
